<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680443</article-id><article-id pub-id-type="doi">10.3390/v16121893</article-id><article-id pub-id-type="publisher-id">viruses-16-01893</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maswanganye</surname><given-names>Carol K.</given-names></name><xref rid="af1-viruses-16-01893" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mkhize</surname><given-names>Pamela P.</given-names></name><xref rid="af2-viruses-16-01893" ref-type="aff">2</xref><xref rid="af3-viruses-16-01893" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Matume</surname><given-names>Nontokozo D.</given-names></name><xref rid="af1-viruses-16-01893" ref-type="aff">1</xref><xref rid="af4-viruses-16-01893" ref-type="aff">4</xref><xref rid="c1-viruses-16-01893" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>DiMaio</surname><given-names>Daniel</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01893"><label>1</label>Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg 3209, South Africa; <email>223020231@stu.ukzn.ac.za</email></aff><aff id="af2-viruses-16-01893"><label>2</label>Discipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg 3209, South Africa; <email>mkhizep6@ukzn.ac.za</email></aff><aff id="af3-viruses-16-01893"><label>3</label>Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal Medical School, Durban 4013, South Africa</aff><aff id="af4-viruses-16-01893"><label>4</label>SAMRC-UNIVEN Antimicrobial Resistance and Global Health Research Unit, HIV/AIDS &#x00026; Global Health Research Programme, University of Venda, Thohoyandou 0950, South Africa</aff><author-notes><corresp id="c1-viruses-16-01893"><label>*</label>Correspondence: <email>matumen@ukzn.ac.za</email> or <email>daphneymatume@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1893</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>03</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>04</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>This systematic review and meta-analysis evaluate human papillomavirus (HPV) prevalence, genotype distribution, and associations with cervicovaginal microbiota and cytokine profiles among South African women, where cervical cancer ranks as the second most common cancer. PubMed, SCOPUS, and Web of Science were searched for studies on HPV infection up to 21 September 2024. The pooled prevalence was estimated using a random-effects model, with subgroup analyses by province, sample type, and HIV status. Publication bias was evaluated using funnel plots and Egger&#x02019;s test. Of the 19,765 studies screened, 120 met the inclusion criteria, comprising 83,266 participants. Results indicate a high HPV burden, with a pooled prevalence of 58% (95% CI: 52&#x02013;64%), varying regionally from 53% (95% CI: 41&#x02013;65%) to 64% (95% CI: 55&#x02013;73%), with some regions under-researched. Cervical samples had the highest HPV prevalence (60% (95% CI: 54&#x02013;66%)), while non-genital samples were less studied. High-risk (HR) HPV types, notably HPV 16 (7.5%), HPV 35 (4.1%), and HPV 18 (3.9%), were prominent, with HPV 35 emphasizing the need for expanded vaccine coverage. HIV-positive women had a higher pooled HPV prevalence (63% (95% CI: 55&#x02013;71%)). Funnel plot analysis and Egger&#x02019;s test suggested a potential publication bias (<italic toggle="yes">p</italic> = 0.047). HPV-positive women exhibited lower Lactobacillus levels and an increase in <italic toggle="yes">Bacterial Vaginosis</italic> (BV)-associated species like <italic toggle="yes">Gardnerella</italic>, potentially supporting HPV persistence. Cytokine analysis showed elevated MIP-1&#x003b1; and MIP-1&#x003b2; in HPV infections, though cytokine profiles may depend on HPV genotypes. These findings underscore the need for research on HPV&#x02013;microbiome-immune interactions and call for comprehensive HPV-prevention strategies, including vaccines targeting regional HPV types and tailored interventions for HIV-positive populations.</p></abstract><kwd-group><kwd>human papillomavirus (HPV)</kwd><kwd>prevalence</kwd><kwd>genotype</kwd><kwd>cytokines</kwd><kwd>cervicovaginal microbiota</kwd><kwd>cervical cancer</kwd></kwd-group><funding-group><award-group><funding-source>PRF</funding-source><award-id>24/81</award-id></award-group><award-group><funding-source>NRF</funding-source><award-id>TTK230430100291</award-id></award-group><funding-statement>This research was supported by PRF, grant number 24/81 and NRF, grant number TTK230430100291.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01893"><title>1. Introduction</title><p>Human papillomavirus (HPV) is predominantly transmitted through sexual contact and targets basal keratinocytes in genital mucosa, oral mucosa, and skin. Over 200 distinct HPV genotypes exist, categorised based on their carcinogenic potential as low risk (LR) and high risk (HR) [<xref rid="B1-viruses-16-01893" ref-type="bibr">1</xref>]. Genital warts are caused by LR-HPV types, while persistent HR-HPV types are associated with precancerous lesions and found in 99.7% of cervical malignancies globally [<xref rid="B2-viruses-16-01893" ref-type="bibr">2</xref>]. Invasive cervical cancer (ICC) represents a significant global health burden, with an age-standardised incidence rate of 13.3 per 100,000 in 2020 [<xref rid="B3-viruses-16-01893" ref-type="bibr">3</xref>]. This cancer disproportionately affects women in developing countries, with evidence suggesting a rising incidence trend in sub-Saharan Africa [<xref rid="B4-viruses-16-01893" ref-type="bibr">4</xref>,<xref rid="B5-viruses-16-01893" ref-type="bibr">5</xref>]. South Africa is one of the countries in sub-Saharan Africa with the highest rates of cervical cancer incidence, making ICC a major leading cause of cancer-related deaths among women [<xref rid="B6-viruses-16-01893" ref-type="bibr">6</xref>].</p><p>HPV is not only responsible for cervical cancer but also implicated in other anatomical areas, including the anus and oral cavity, where it has been identified as a significant etiological factor in anal and oropharyngeal cancers [<xref rid="B7-viruses-16-01893" ref-type="bibr">7</xref>,<xref rid="B8-viruses-16-01893" ref-type="bibr">8</xref>,<xref rid="B9-viruses-16-01893" ref-type="bibr">9</xref>,<xref rid="B10-viruses-16-01893" ref-type="bibr">10</xref>]. Oncogenic HPV types are estimated to cause 90% of anal squamous cancers [<xref rid="B11-viruses-16-01893" ref-type="bibr">11</xref>]. Approximately 30% of oral cancer cases are linked to HPV, with most other cases associated with smoking and alcohol use [<xref rid="B12-viruses-16-01893" ref-type="bibr">12</xref>]. While HPV infections in the oral and anal regions occur less frequently than cervical infections, they are more common among individuals with compromised immune systems, including those living with human immunodeficiency virus (HIV) [<xref rid="B13-viruses-16-01893" ref-type="bibr">13</xref>]. Previous studies have linked these cancers to HR-HPV-16 [<xref rid="B11-viruses-16-01893" ref-type="bibr">11</xref>,<xref rid="B14-viruses-16-01893" ref-type="bibr">14</xref>]. However, current epidemiological and molecular evidence supporting a causal relationship remains limited, as it primarily revolves around detecting HPV genomes in tumour cells without more definitive conclusions. Data on oral and anal HPV infections in African settings are scarce, highlighting a significant gap in understanding the role of HPV in these cancers within this population.</p><p>In South African women, HR-HPV genotypes, notably HPV-16 and HPV-18, along with LR-HPV types such as HPV-6 and HPV-11, are predominant, reflecting global patterns [<xref rid="B15-viruses-16-01893" ref-type="bibr">15</xref>]. Other significant HR-HPV types including HPV-31, HPV-33, HPV-35, HPV-39, HPV-45, HPV-51, HPV-52, HPV-56, HPV-58, HPV-66, and HPV-68 [<xref rid="B16-viruses-16-01893" ref-type="bibr">16</xref>,<xref rid="B17-viruses-16-01893" ref-type="bibr">17</xref>,<xref rid="B18-viruses-16-01893" ref-type="bibr">18</xref>] are at an increasing rate globally. HPV-35, HPV-39, HPV-51, HPV-56, HPV-59, HPV-66, and HPV-68 are more prevalent in Africa than elsewhere and are not covered by existing vaccines. HPV-35 is detected in around 10% of cervical cancer cases in Africa, compared to its detection in about 2% globally [<xref rid="B19-viruses-16-01893" ref-type="bibr">19</xref>]. Currently, three HPV vaccines are commercially available: Cervarix<sup>&#x000ae;</sup>, Gardasil<sup>&#x000ae;</sup>, and Gardasil<sup>&#x000ae;</sup>9 [<xref rid="B20-viruses-16-01893" ref-type="bibr">20</xref>]. The bivalent vaccine Cervarix<sup>&#x000ae;</sup> targets the two most prevalent HR-HPV types, HPV-16 and HPV-18, while Gardasil<sup>&#x000ae;</sup>, a quadrivalent vaccine protects against both HR types (HPV-16 and 18) as well as two LR types (HPV-6 and 11) that cause genital warts [<xref rid="B21-viruses-16-01893" ref-type="bibr">21</xref>]. The nonavalent vaccine Gardasil<sup>&#x000ae;</sup>9 offers broader protection by targeting nine HPV genotypes, covering four types from the bivalent and quadrivalent vaccines (HPV-16, 18, 6, and 11) and five additional strains associated with cervical cancer (HPV-31, 33, 45, 52, and 58) [<xref rid="B22-viruses-16-01893" ref-type="bibr">22</xref>].</p><p>Although the introduction of prophylactic HPV vaccines represents a major breakthrough in cancer prevention, achieving access and widespread immunisation coverage remains challenging [<xref rid="B23-viruses-16-01893" ref-type="bibr">23</xref>]. Many young women in sub-Saharan Africa continue to be significantly impacted by HPV infections. Persistent HR-HPV infection alone does not always result in cervical intraepithelial neoplasia (CIN) or ICC. Other factors, such as immune responses, cervicovaginal microbiota, and HIV status, play significant roles [<xref rid="B24-viruses-16-01893" ref-type="bibr">24</xref>,<xref rid="B25-viruses-16-01893" ref-type="bibr">25</xref>]. Women living with HIV exhibit a greater prevalence of genital HR-HPV infections compared to the general population [<xref rid="B26-viruses-16-01893" ref-type="bibr">26</xref>], and HIV co-infection with HR-HPV is associated with an increased risk of progressing to CIN or cervical cancer, likely due to the immunosuppressive effects of HIV [<xref rid="B27-viruses-16-01893" ref-type="bibr">27</xref>]. Furthermore, studies have indicated a potential connection between vaginal microbiota and CIN development, suggesting that a dysbiotic vaginal environment may significantly influence the onset and progression of CIN [<xref rid="B28-viruses-16-01893" ref-type="bibr">28</xref>,<xref rid="B29-viruses-16-01893" ref-type="bibr">29</xref>]. Vaginal dysbiosis, characterised by an overgrowth of anaerobic bacteria, promotes HPV persistence and progression by creating favourable conditions for the virus [<xref rid="B30-viruses-16-01893" ref-type="bibr">30</xref>]. This imbalance, often leading to <italic toggle="yes">Bacterial Vaginosis</italic> (BV) [<xref rid="B31-viruses-16-01893" ref-type="bibr">31</xref>], disrupts the local immune response, hindering the host&#x02019;s ability to clear HPV infections.</p><p>A competent immune system is crucial for the clearance of viral infections [<xref rid="B24-viruses-16-01893" ref-type="bibr">24</xref>]. Recent studies suggest a significant correlation between immune status and viral infection, with the vaginal microbiota playing a role in modulating the immune system of the female genital tract (FGT) [<xref rid="B32-viruses-16-01893" ref-type="bibr">32</xref>,<xref rid="B33-viruses-16-01893" ref-type="bibr">33</xref>]. Previous data indicate a correlation between changes in cytokine profiles and BV, rather than HPV infection. Few studies have examined cytokine profiles in HPV-infected and uninfected women, and uncertainties remain regarding which HPV genotypes correlate with specific cytokine profile signatures.</p><p>This study aimed to systematically review HPV research conducted in South Africa and perform a meta-analysis to uncover factors influencing the prevalence and regional distribution of HPV genotypes in South African women. Additionally, we assessed how HIV status impacts HPV infections and examined the roles of cytokine profiles and cervicovaginal microbiota in HPV prevalence and progression. By considering interactions among HPV, the microbiome, and cytokines, this study aims to inform potential strategies for cervical cancer prevention and treatment.</p></sec><sec sec-type="methods" id="sec2-viruses-16-01893"><title>2. Methodology</title><sec id="sec2dot1-viruses-16-01893"><title>2.1. Study Design and Search Strategy</title><p>This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [<xref rid="B34-viruses-16-01893" ref-type="bibr">34</xref>]. The review was not registered due to time constraints and the large number of studies being conducted in this area. Relevant articles examining HPV infection in South African women, the composition of cervicovaginal microbiota in relation to HPV, and cytokine profiles associated with HPV in this population were identified through advanced search strategies in the PubMed, Web of Science, and Scopus databases, using specified search terms. The final search for this systematic review and meta-analysis was completed on 21 September 2024. The search strategies and search terms used for each database are detailed below.</p></sec><sec id="sec2dot2-viruses-16-01893"><title>2.2. Search Terms</title><sec id="sec2dot2dot1-viruses-16-01893"><title>2.2.1. PubMed</title><p>Search: ((((((Human papillomavirus) OR (Human Papilloma virus)) OR (Papillomaviridae)) OR (HPV)) AND (Women)) OR (Female)) AND (South Africa*) Filters: Books and Documents, Clinical Trial, Randomized Controlled Trial, English.</p><p>((((&#x0201c;human papillomavirus viruses&#x0201d;[MeSH Terms] OR (&#x0201c;human&#x0201d;[All Fields] AND &#x0201c;papillomavirus&#x0201d;[All Fields] AND &#x0201c;viruses&#x0201d;[All Fields]) OR &#x0201c;human papillomavirus viruses&#x0201d;[All Fields] OR (&#x0201c;human&#x0201d;[All Fields] AND &#x0201c;papillomavirus&#x0201d;[All Fields]) OR &#x0201c;human papillomavirus&#x0201d;[All Fields] OR (&#x0201c;human papillomavirus viruses&#x0201d;[MeSH Terms] OR (&#x0201c;human&#x0201d;[All Fields] AND &#x0201c;papillomavirus&#x0201d;[All Fields] AND &#x0201c;viruses&#x0201d;[All Fields]) OR &#x0201c;human papillomavirus viruses&#x0201d;[All Fields] OR (&#x0201c;human&#x0201d;[All Fields] AND &#x0201c;papilloma&#x0201d;[All Fields] AND &#x0201c;virus&#x0201d;[All Fields]) OR &#x0201c;human papilloma virus&#x0201d;[All Fields]) OR (&#x0201c;papillomaviridae&#x0201d;[MeSH Terms] OR &#x0201c;papillomaviridae&#x0201d;[All Fields]) OR &#x0201c;HPV&#x0201d;[All Fields]) AND (&#x0201c;womans&#x0201d;[All Fields] OR &#x0201c;women&#x0201d;[MeSH Terms] OR &#x0201c;women&#x0201d;[All Fields] OR &#x0201c;woman&#x0201d;[All Fields] OR &#x0201c;women s&#x0201d;[All Fields] OR &#x0201c;womens&#x0201d;[All Fields])) OR (&#x0201c;femal&#x0201d;[All Fields] OR &#x0201c;female&#x0201d;[MeSH Terms] OR &#x0201c;female&#x0201d;[All Fields] OR &#x0201c;females&#x0201d;[All Fields] OR &#x0201c;female s&#x0201d;[All Fields] OR &#x0201c;femals&#x0201d;[All Fields])) AND (&#x0201c;South&#x0201d;[All Fields] AND &#x0201c;africa*&#x0201d;[All Fields])) AND ((booksdocs[Filter] OR clinicaltrial[Filter] OR randomizedcontrolledtrial[Filter]) AND (english[Filter])).</p></sec><sec id="sec2dot2dot2-viruses-16-01893"><title>2.2.2. Scopus</title><p>TITLE-ABS (human AND papillomavirus) OR TITLE-ABS-KEY (hpv) OR TITLE-ABS (human AND papilloma AND virus) AND ALL (women) OR ALL (female) AND ALL (south AND africa*) AND (LIMIT-TO (LANGUAGE, &#x0201c;English&#x0201d;)).</p></sec><sec id="sec2dot2dot3-viruses-16-01893"><title>2.2.3. Web of Science</title><p>((((((TS = (Human Papillomavirus)) OR TS = (Human Papilloma virus)) OR TS = (Papillomaviridae)) OR TS = (HPV)) AND TS = (Women)) OR TS = (Female)) AND TS = (South Africa*).</p><p>Refined By: Language: English, Document types: Article.</p></sec></sec><sec id="sec2dot3-viruses-16-01893"><title>2.3. Eligibility Criteria</title><p>Eligible studies for inclusion were full-text experimental research articles published in English, focusing on the following criteria: (1) HPV genotype distribution among HPV-positive South African women, regardless of HIV status; (2) research conducted in other countries that used samples from South African women; (3) all types of samples tested for HPV, regardless of infection stage or the genotyping methods used for HPV detection. The exclusion criteria were based on six key factors: (1) papers lacking methodological transparency; (2) papers that did not report on HPV DNA, HPV mRNA or utilising histological or serological methods (e.g., ELISA); (3) papers not geographically relevant (South Africa had to be included in comparative studies); (4) studies reporting on HPV in men; (5) publications in languages other than English; and (6) publications without original data (such as reviews, conference papers, guidelines, letters, and editorials).</p></sec><sec id="sec2dot4-viruses-16-01893"><title>2.4. Data Extraction</title><p>The records identified from the databases were downloaded in a suitable format and exported to the Endnote referencing tool. Duplicates were identified and removed using Endnote&#x02019;s &#x0201c;Find Duplicates&#x0201d; feature. Titles and abstracts were then thoroughly screened, and the remaining records were assessed for eligibility by downloading and reviewing the full articles. The reviewers extracted data from the papers using Microsoft<sup>&#x000ae;</sup> Excel 365 spreadsheets. The following variables were extracted: first author, title, year of publication, total sample size, number of HPV-positive cases, study period, study design, study location, detection methods, sample type, and province; these items are provided in the <xref rid="app1-viruses-16-01893" ref-type="app">Supplementary Data</xref>. Any disagreements were resolved by discussing inconsistencies until a consensus was reached.</p><p>The articles were thoroughly analysed and grouped into four objectives as follows: (Objective 1) articles were included to determine the prevalence and distribution of HPV genotypes in South African women; (Objective 2) articles were included to assess the prevalence of HPV genotypes based on HIV status in South African women; (Objective 3) articles were included to examine the cervicovaginal microbiota composition and its correlation with HPV in South African women; and (Objective 4) articles were included to investigate the cytokine profiles associated with HPV in South African women (<xref rid="viruses-16-01893-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2dot5-viruses-16-01893"><title>2.5. Study Quality and Bias Assessment</title><p>Two reviewers, N.D.M. and C.K.M., independently assessed the quality of all included articles using the Joanna Briggs Institute (JBI), a Critical Review Checklist for Studies Reporting Prevalence Data [<xref rid="B35-viruses-16-01893" ref-type="bibr">35</xref>]. Each study was categorised by its design and evaluated using a set of questions tailored to that design. Any disagreements between the reviewers were resolved through discussion and consensus. If consensus could not be reached, a third reviewer, P.P.M., was consulted for further input.</p></sec><sec id="sec2dot6-viruses-16-01893"><title>2.6. Statistical Analysis</title><p>The 95% confidence intervals (CIs) for the pooled prevalence estimates were analysed using the &#x0201c;meta&#x0201d; (version 8.0-1) and &#x0201c;metafor&#x0201d; (version 4.6-0) packages in RStudio for the meta-analysis. Forest plots were generated to visualise the prevalence of HPV and assess heterogeneity across studies. Heterogeneity was evaluated using the I<sup>2</sup> statistic and Cochran&#x02019;s Q test, with <italic toggle="yes">p</italic> &#x0003c; 0.1 indicating significant heterogeneity. I<sup>2</sup> values above 50% were considered to reflect substantial variability among studies. Heterogeneity was categorised as follows: I<sup>2</sup> values of 0%, &#x0003c;25%, 25&#x02013;50%, and &#x0003e;50% indicating no heterogeneity, low heterogeneity, moderate heterogeneity, and high heterogeneity, respectively [<xref rid="B36-viruses-16-01893" ref-type="bibr">36</xref>,<xref rid="B37-viruses-16-01893" ref-type="bibr">37</xref>]. As a result, a random-effects model (restricted maximum-likelihood method) was applied rather than a fixed-effects model. To address the high heterogeneity, subgroup analyses were conducted based on province, sample type, and HIV status. In the province-specific subgroup analysis, studies that did not specify the province(s) from which samples were obtained, or that included participants from multiple provinces without disaggregated data, were excluded. For the subgroup meta-analysis by HIV status, studies were included only if they explicitly reported HPV prevalence according to the participants&#x02019; HIV status. Studies that either did not specify HIV status or combined HPV data from both HIV-positive and HIV-negative participants were excluded from this analysis to ensure specificity in the results. In the subgroup analysis by sample type, studies reporting HPV prevalence from two different sample types collected from the same participants were treated as separate populations. This approach allowed each sample type to be analysed independently, ensuring that the data accurately reflected each sample type and enabling more precise subgroup comparisons. Consequently, these exclusions may have affected the random-effects model, potentially altering the overall HPV prevalence estimate by approximately 1%. For sensitivity analysis both fixed-effect and random-effects models were assessed to determine the robustness of the pooled HPV prevalence estimate. The contrast in the results of both the models highlights the impact among the studies variability on the pooled prevalence. In the forest plot for subgroup analysis, the chi-square statistic (&#x003c7;<sup>2</sup>) was used to test for differences across subgroups, with <italic toggle="yes">p</italic>-values &#x0003c; 0.05 indicating greater variability between them.</p><p>The extracted genotype data for HR-HPV types, LR-HPV types, and probable HR-HPV types were grouped under the HR-HPV category for analysis. When studies presented data from multiple detection methods, the method with the highest sensitivity was selected to ensure consistency across the studies included in the meta-analysis. For studies reporting HPV results at multiple follow-up time points (e.g., 6-month and 12-month follow-ups), data from the earliest time point within each period were extracted. This approach was adopted as participation typically decreases at later follow-ups, which could lead to an underestimation of HPV prevalence.</p><p>The synthesis of microbiota data included only studies reporting the composition of specific bacterial species to maintain consistency in analysis. Data on bacterial species were extracted and grouped based on their presence in HPV-positive and high-risk HPV (HR-HPV) individuals. Studies reporting microbiota data in other formats, such as the number of individuals with bacterial vaginosis (BV)-associated microbiota by HPV status, were excluded to maintain consistency. However, these data were used to support and validate the overall findings on bacterial species distribution according to HPV status.</p><p>For cytokine profile data, not all studies used the same categories. To enable comparative analysis, cytokine data were standardised into a common format. This was necessary as some studies differentiated cytokine levels by HPV-negative and HPV-positive status, while others included subgroup analyses based on HIV status or BV status alongside HPV infection. This approach ensured consistent analysis and synthesis of cytokine data across the included studies.</p></sec></sec><sec sec-type="results" id="sec3-viruses-16-01893"><title>3. Results</title><sec id="sec3dot1-viruses-16-01893"><title>3.1. Study and Population Characteristics</title><p>Our search strategy identified a total of 20,330 records from PubMed (n = 4902), Scopus (n = 4505), and Web of Science (n = 10,923). After removing 565 duplicates, 19,765 articles were included in the screening process. Of these, 19,479 articles were excluded after reviewing the titles and abstracts. Following the application of our inclusion and exclusion criteria, 120 studies were included in the meta-analysis after reviewing the full texts of 279 articles (<xref rid="viruses-16-01893-f001" ref-type="fig">Figure 1</xref> and <xref rid="viruses-16-01893-t001" ref-type="table">Table 1</xref>). Excluded studies and reasons for exclusion are recorded in <xref rid="app1-viruses-16-01893" ref-type="app">Table S1</xref>.</p><p>The data from the 120 included studies were conducted across five provinces in South Africa, Eastern Cape, Gauteng, KwaZulu-Natal, Limpopo, and Western Cape, spanning from 1989 to 2024. Notably, no studies were reported from the remaining four provinces of the country. In total, the studies included 83,266 women as participants (<xref rid="viruses-16-01893-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot2-viruses-16-01893"><title>3.2. Pooled Prevalence of HPV Infection in South Africa</title><p>The overall prevalence of HPV infection in South African women, as reported in the included studies, was assessed irrespective of HIV status and sample type (<xref rid="viruses-16-01893-f002" ref-type="fig">Figure 2</xref>). Using the fixed-effects model, the pooled HPV prevalence was estimated at 33% (95% CI: 33&#x02013;34%). However, due to the significant variability across studies, the random-effects model, which accounts for differences between studies, provides a more reliable estimate of 58% (95% CI: 52&#x02013;64%). The heterogeneity among the studies was substantial, with an I<sup>2</sup> of 99.1% and &#x003c4;<sup>2</sup> = 0.9489 (<italic toggle="yes">p</italic> &#x0003c; 0.001), indicating that the variation in HPV prevalence across studies was not due to chance, but likely reflects differences in study populations and methodologies. This high level of heterogeneity justifies the use of the random-effects model to accurately summarise the true burden of HPV in this population.</p></sec><sec id="sec3dot3-viruses-16-01893"><title>3.3. Pooled Prevalence of HPV Infection by Province</title><p>The meta-analysis revealed varying HPV prevalence rates among women across different provinces in South Africa (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S1</xref>). Gauteng had the highest prevalence at 64% (95% CI: 55&#x02013;73%), followed by Eastern Cape at 63% (95% CI: 39&#x02013;84%) and Limpopo at 59% (95% CI: 44&#x02013;72%). KwaZulu-Natal and Western Cape had similar prevalence rates of 53% (95% CI: 41&#x02013;65%) and 53% (95% CI: 43&#x02013;62%), respectively. The random-effects model indicated significant heterogeneity across studies (I<sup>2</sup> = 99.4%, &#x003c4;<sup>2</sup> = 0.0917, <italic toggle="yes">p</italic> &#x0003c; 0.001), suggesting that the observed differences in prevalence are due to genuine variations in study populations and methodologies, rather than random chance. The test for subgroup differences showed no statistically significant differences in HPV prevalence between provinces (&#x003c7;<sup>2</sup> = 3.48, df = 4, <italic toggle="yes">p</italic> = 0.48). This suggests that, although certain provinces show slightly higher or lower prevalence rates, the overall HPV prevalence remains high across the country.</p></sec><sec id="sec3dot4-viruses-16-01893"><title>3.4. Geographic Distribution of the Sample Types Studied Among South African Provinces</title><p>The geographic distribution of sample types studied across South African provinces was analysed (<xref rid="viruses-16-01893-f003" ref-type="fig">Figure 3</xref>). Cervical samples were the most frequently investigated, featured in 92 studies, primarily from the Western Cape (38 studies) and Gauteng (24 studies), with additional research from KwaZulu-Natal, Eastern Cape, and Limpopo. Vaginal samples were included in 12 studies, the majority of which (6 studies) came from KwaZulu-Natal, followed by studies from the Western Cape, Eastern Cape, and Gauteng. There were both cervical and oral samples (5 studies, predominantly from the Western Cape). Oral samples were collected in four studies, mainly from Gauteng and the Western Cape, while anal samples were limited to two studies from Gauteng. Less common sample types included breast tissue (1 study, Gauteng), laryngeal samples (1 study, Western Cape) and cervical and blood samples (1 study, Western Cape). Biopsy samples from genital warts were analysed in one study in Western Cape Province.</p></sec><sec id="sec3dot5-viruses-16-01893"><title>3.5. Pooled Prevalence of HPV Infection by Sample Type</title><p>The meta-analysis assessed HPV prevalence across various sample types, revealing significant variation (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S2</xref>). Using a random-effects model, the overall pooled prevalence of HPV was calculated, showing considerable heterogeneity across sample types (I<sup>2</sup> = 99.4%, &#x003c4;<sup>2</sup> = 0.1003, <italic toggle="yes">p</italic> &#x0003c; 0.01). Cervical samples had the highest pooled prevalence at 60% (95% CI: 53&#x02013;66%), followed by vaginal samples at 53% (95% CI: 39&#x02013;67%). Anal samples showed a prevalence of 42% (95% CI: 37&#x02013;47%), while oral samples had a lower prevalence of 25% (95% CI: 9&#x02013;47%). Genital wart biopsy, blood, and breast tissue samples displayed relatively lower prevalence rates, ranging from 17% to 37%. Laryngeal samples had the lowest prevalence at 0.12%. The test for subgroup differences revealed significant variability between sample types (&#x003c7;<sup>2</sup> = 514.15, df = 7, <italic toggle="yes">p</italic> &#x0003c; 0.01), highlighting that the type of biological sample plays a critical role in determining HPV prevalence. The observed heterogeneity indicates that these differences in HPV prevalence are due to genuine variations based on sample type, rather than random variation.</p></sec><sec id="sec3dot6-viruses-16-01893"><title>3.6. Pooled Prevalence of HPV Infection by HIV Status</title><p>The meta-analysis evaluated the prevalence of HPV based on HIV status among women (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S3</xref>). Using a random-effects model, the HPV prevalence was estimated, revealing significant heterogeneity across studies and sample types (I<sup>2</sup> = 99%, &#x003c4;<sup>2</sup> = 0.0821, <italic toggle="yes">p</italic> &#x0003c; 0.001). HIV-positive women had the highest prevalence at 63% (95% CI: 55&#x02013;71%), while HIV-negative women had the lowest prevalence at 39% (95% CI: 29&#x02013;50%). The test for subgroup differences showed significant variability between sample types (&#x003c7;<sup>2</sup> = 11.89, df = 1, <italic toggle="yes">p</italic> &#x0003c; 0.01), emphasising the differences in HPV prevalence based on HIV status among women.</p></sec><sec id="sec3dot7-viruses-16-01893"><title>3.7. Overall HR-HPV Genotype Prevalence</title><p>The prevalence of high-risk (HR) HPV genotypes across detection periods from 1989 to 2024 was summarised in 70 studies (<xref rid="viruses-16-01893-f004" ref-type="fig">Figure 4</xref>). The prevalence rates of the 22 HR-HPV genotypes reported ranged from 0.1% to 7.6%. The most prevalent genotype was HPV-16, detected in 65 studies from 1989 to 2024, with a prevalence of 7.50%. This was followed by HPV-35 (4.11%) and HPV-18 (3.87%). The widespread detection of HPV-16 and HPV-35 highlights their significant presence in the population, making them the most prevalent HR-HPV genotypes in this analysis. Other notable high-risk genotypes include HPV-52 (3.42%), HPV-58 (2.98%), and HPV-45 (2.95%). Lower-prevalence types, such as HPV-26 (0.19%) and HPV-67 (0.16%), were also observed. These results provide a comprehensive overview of the distribution of HR-HPV genotypes over time, with the detection periods indicating when each genotype was first and most recently identified.</p></sec><sec id="sec3dot8-viruses-16-01893"><title>3.8. The Trends in the Detection of the Most Prevalent HR-HPV Genotypes Studied (16, 18, 35, and 52) from 2005 to 2024</title><p>Over the observed period from 2005 to 2024, the prevalence of high-risk (HR) HPV genotypes 16, 18, 35, and 52 showed significant variability (<xref rid="viruses-16-01893-f005" ref-type="fig">Figure 5</xref>). These findings highlight the persistence of HPV-16 as the most prevalent type, with fluctuations in the detection rates of HPV-18, 35, and 52 over time. HPV-16 consistently exhibited the highest detection rates, maintaining a strong presence throughout the years from 2005 to 2024. Similarly, HPV-18 had high detection rates during this period, while HPV-35 showed sporadic detections and HPV-52 was only detected from 2006 onwards. Notably, from 2015, HPV-35 had higher detection rates than HPV-18, with both genotypes showing varying levels of detection, each peaking in different periods but generally remaining within the 0&#x02013;20% range. HPV-52, among the other genotypes, had lower detection rates but remained relatively consistent throughout the observed period. The peaks in 2015 for all four HPV types may indicate a period of increasing detection or prevalence, possibly reflecting improvements in testing or diagnostic methods. However, there were years, such as 2013 and 2020, in which one or more HPV genotypes were not detected, suggesting potential changes in diagnostic capabilities or shifts in research focus.</p></sec><sec id="sec3dot9-viruses-16-01893"><title>3.9. HR-HPV Genotype Prevalence in Female Genital Tract and Upper Respiratory Tract</title><p>The prevalence of high-risk (HR) HPV genotypes in female genital tract (FGT) samples (including cervical and vaginal samples) among South African women was assessed from 1989 to 2024 across 65 studies (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S4A</xref>). In contrast, HR-HPV was detected in upper respiratory tract (URT) samples (including oral and laryngeal samples) from 2002 to 2020 across three studies (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S4B</xref>). HPV-16 was the most common genotype found in both sample types, with a prevalence of 6.61% in FGT samples and 7.24% in URT samples. This was followed by HPV-35 (3.65%) and HPV-18 (3.48%) in FGT samples. However, in URT samples, HPV-18 (2.41%) was the second most prevalent genotype, while HPV-35 was not detected. Other notable genotypes included HPV-52 (3.11%) and HPV-58 (2.98%) in FGT samples, and HPV-33 (1.61%) and HPV-68 (0.54%) in URT samples. Similar trends were observed across both sample types, with low prevalence of HPV-70 and HPV-83. These genotypes were the least prevalent in URT samples, both at 0.27%. In FGT samples, the lowest prevalence was observed for HPV-67 and HPV-26, with both showing a prevalence of less than 0.2%. These data reflect the distribution of HR-HPV genotypes in FGT and URT samples collected over time.</p></sec><sec id="sec3dot10-viruses-16-01893"><title>3.10. Overall LR-HPV Genotype Prevalence</title><p>The prevalence of low-risk (LR) HPV genotypes across the included studies, covering detection periods from 1991 to 2023 were analysed (<xref rid="viruses-16-01893-f006" ref-type="fig">Figure 6</xref>). Overall, the prevalence of LR-HPV genotypes ranged from 0.1% to 6.0% across all 28 studies. The most prevalent genotype was HPV-62, with a prevalence of 5.80%, followed by HPV-6 (5.47%), HPV-84 (5.26%), and HPV-11 (4.73%). This widespread detection highlights the significant presence of HPV-62 and HPV-84 in the population. Other notable LR genotypes included HPV-61 (4.35%), and HPV-81 and HPV-54, both with prevalences of less than 3.1%. The lowest prevalence was observed for HPV-43 and HPV-74, both with a prevalence of 0.17%.</p></sec><sec id="sec3dot11-viruses-16-01893"><title>3.11. LR-HPV Genotype Prevalence in Female Genital Tract and Upper Respiratory Tract Sample Types</title><p>The prevalence of low-risk (LR) HPV genotypes in the female genital tract (FGT) and upper respiratory tract (URT) regions, as observed from 1991 to 2023, showed considerable variation (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S5</xref>). Across all 18 LR-HPV genotypes, prevalence rates ranged from 0.1% to 6.0% in FGT samples and from 0.4% to 19% in URT samples. In FGT samples, HPV-62 was the most prevalent genotype at 5.84%, followed closely by HPV-6&#x02014;a globally common type&#x02014;at 5.47%, and HPV-84 at 5.30%. HPV-11, another globally common type, showed a prevalence of 4.4%. Other notable LR genotypes in FGT samples included HPV-61 (4.38%), HPV-81 (3.17%), and HPV-54 (3.10%).</p><p>In comparison, HPV-11 was the most prevalent genotype in URT samples, with a prevalence of 18.38%, followed by HPV-6 and HPV-72, both at 2.70%. Less prevalent genotypes in URT samples included HPV-61, HPV-71, HPV-81, HPV-84, and HPV-89, each with a prevalence of 0.54%. These data provide a comprehensive overview of the distribution of LR-HPV types in FGT and URT samples over time.</p></sec><sec id="sec3dot12-viruses-16-01893"><title>3.12. Prevalence of HR and LR-HPV Genotypes Stratified by HIV Status</title><p>The distribution of high-risk (HR) HPV genotypes was analysed in both HIV-positive and HIV-negative women (<xref rid="viruses-16-01893-f007" ref-type="fig">Figure 7</xref>). Among HIV-negative women, HPV-16 was the most prevalent genotype, accounting for 3.92% of infections, followed by HPV-35 (2.56%) and HPV-18 (1.71%). The least prevalent genotypes in this group were HPV-26, HPV-69, and HPV-83. In contrast, HIV-positive women showed a higher prevalence of HR-HPV genotypes, with HPV-16 also being the most common, detected in 11.01% of cases. Other frequently detected genotypes in this group included HPV-18 (6.41%), HPV-35 (6.15%), and HPV-45 (5.89%). Low-prevalence HR-HPV genotypes in HIV-positive women included HPV-67 and HPV-70, with detection rates of 0.02% and 0.69%, respectively, while these were undetected in HIV-negative women.</p><p>The distribution of low-risk (LR) HPV genotypes also differed significantly between HIV-positive and HIV-negative South African women (<xref rid="viruses-16-01893-f008" ref-type="fig">Figure 8</xref>). In HIV-positive women, the most prevalent LR-HPV genotypes were HPV-62 (9.66%) and HPV-11 (8.97%), followed by HPV-61 (8.45%) and HPV-83 (5.17%). Genotypes with low prevalence rates in this group included HPV-42 (0.34%), HPV-40 (0.52%), and HPV-71 (0.52%). Among HIV-negative women, the most prevalent LR-HPV genotypes were HPV-11 (5.21%), HPV-6 (4.17%), and HPV-72 (1.88%), with other notable genotypes including HPV-40, HPV-81, and HPV-84, each at 1.25%. Overall, LR-HPV genotypes, particularly HPV-6 and HPV-11, were more prevalent in HIV-positive women compared to HIV-negative women.</p></sec><sec id="sec3dot13-viruses-16-01893"><title>3.13. Association Between Cervicovaginal Microbiota and HPV Infection</title><p>The <italic toggle="yes">network analysis</italic> provides a comparative summary of all bacterial species found to be either significantly or non-significantly correlated with various HPV infections from two key studies included in this review [<xref rid="B124-viruses-16-01893" ref-type="bibr">124</xref>,<xref rid="B145-viruses-16-01893" ref-type="bibr">145</xref>] (<xref rid="viruses-16-01893-f009" ref-type="fig">Figure 9</xref>). Additional studies [<xref rid="B118-viruses-16-01893" ref-type="bibr">118</xref>,<xref rid="B131-viruses-16-01893" ref-type="bibr">131</xref>,<xref rid="B134-viruses-16-01893" ref-type="bibr">134</xref>,<xref rid="B140-viruses-16-01893" ref-type="bibr">140</xref>,<xref rid="B141-viruses-16-01893" ref-type="bibr">141</xref>] contributed supplementary findings; however, direct quantitative comparisons were constrained by inconsistencies in data reporting and variation in the bacterial species studied. Nonetheless, these studies consistently indicated that individuals with HPV were more likely to exhibit a microbiome highly associated with <italic toggle="yes">BV</italic> compared to HPV-negative individuals.</p><p>In the HPV-negative/<italic toggle="yes">LR-HPV</italic>-positive category, <italic toggle="yes">Lactobacillus crispatus</italic> was significantly correlated, suggesting a microbiome dominated by lactobacilli, which is typically considered protective. Other species showing significant associations included <italic toggle="yes">Corynebacterium tuberculostearicum</italic>, <italic toggle="yes">Corynebacterium amycolatum/Corynebacterium lactis</italic>, <italic toggle="yes">Pasteurellales</italic>, <italic toggle="yes">Alphaproteobacteria</italic>, <italic toggle="yes">Gammaproteobacteria</italic>, <italic toggle="yes">Pseudomonadales</italic>, <italic toggle="yes">Phyllobacterium</italic>, and <italic toggle="yes">Rhizobiales</italic>.</p><p>Bacterial species positively correlated with HPV positivity included a mixture of <italic toggle="yes">BV</italic>-associated bacteria. Significant correlations with HPV-positive infection were observed for <italic toggle="yes">Aerococcus christensenii</italic>, <italic toggle="yes">Prevotella</italic>, <italic toggle="yes">Atopobium vaginae</italic>, <italic toggle="yes">Gardnerella vaginalis</italic>, <italic toggle="yes">Coriobacteriaceae</italic>, <italic toggle="yes">Dialister micraerophilus</italic>, <italic toggle="yes">Dialister succinatiphilus/D. propionifaciens</italic>, <italic toggle="yes">Megasphaera</italic>, <italic toggle="yes">Fannyhessea vaginae</italic>, <italic toggle="yes">Gemella asaccharolytica</italic>, <italic toggle="yes">Peptoniphilus lacrimalis</italic>, and <italic toggle="yes">Parvimonas micra</italic>. Notably, <italic toggle="yes">Prevotella</italic>, <italic toggle="yes">Megasphaera</italic>, and <italic toggle="yes">Gardnerella vaginalis</italic> demonstrated strong associations with <italic toggle="yes">BV</italic>.</p><p>In HR-HPV-positive women, a distinct microbial composition was observed, including Bifidobacteriales, Bifidobacteriaceae, Aerococcus, Aerococcaceae, Coriobacteriales, Coriobacteriaceae, Fusobacteriales, Fusobacteria, Actinobacteria, Gardnerella, Gardnerella vaginalis, Atopobium, Atopobium vaginae, Leptotrichiaceae, and Sneathia. Among these, Coriobacteriales, Actinobacteria, Fusobacteria, Fusobacteriales, Gardnerella, Gardnerella vaginalis, Atopobium, and Atopobium vaginae were significantly associated with BV, indicating a distinct microbiome profile in HR-HPV cases characterised by a higher prevalence of BV-associated bacteria.</p></sec><sec id="sec3dot14-viruses-16-01893"><title>3.14. HPV Infection Association with Cervicovaginal Cytokine Profile</title><p>The relationship between HPV infection and cervicovaginal cytokine levels was analysed using data from three key studies [<xref rid="B105-viruses-16-01893" ref-type="bibr">105</xref>,<xref rid="B123-viruses-16-01893" ref-type="bibr">123</xref>,<xref rid="B145-viruses-16-01893" ref-type="bibr">145</xref>]. These studies collectively measured 55 cytokines, offering a detailed overview of immune responses in the cervicovaginal environment across different infection statuses. The Venn diagrams illustrate cytokine profiles associated with HPV positivity, HIV positivity, and BV presence in cervicovaginal samples, highlighting both shared and unique cytokine signatures for each condition. Cytokines significantly associated with each category, adjusted for multiple comparisons, are marked with an asterisk in boxes adjacent to each category in the Venn diagram (<xref rid="viruses-16-01893-f010" ref-type="fig">Figure 10</xref>).</p><p>In HPV-negative individuals, IL-10, IL-15, and MCP-3 were detected at lower levels, although these differences did not reach statistical significance. Conversely, HPV-positive individuals displayed elevated levels of IL-1&#x003b2;, IL-17F, IL-25, IL-33, and TNF-&#x003b1;, which overlapped with cytokine profiles associated with BV. However, following adjustments for multiple comparisons, these cytokines (IL-1&#x003b2;, IL-17F, IL-25, IL-33, and TNF-&#x003b1;) were significantly associated only with BV. In the HIV-positive group, there was an overlap in elevated levels of IP-10, IL-8, and IL-6, shared with the HPV-positive category. Additionally, cytokines IL-1&#x003b1;, IL-6, IP-10, G-CSF, and MCP-1 were significantly associated with HIV positivity. Women infected with HPV had notably higher mucosal concentrations of MIP-1&#x003b1; and MIP-1&#x003b2;, suggesting a distinct cytokine profile associated with HPV positivity.</p><p>Happel et al. [<xref rid="B145-viruses-16-01893" ref-type="bibr">145</xref>] found that cervicovaginal cytokine levels varied by HPV genotype. High-risk HPV types 35, 39, and 68 were associated with elevated levels of cytokines such as IL-17A, IL-17F, IL-25, TNF-&#x003b1;, and IFN-&#x003b3;, while HPV-30 was linked to reduced cytokine levels. HPV-35 infection remained significantly associated with elevated levels of six cytokines, including IL-1&#x003b2; and TNF-&#x003b1;, even after controlling for multiple comparisons and BV status.</p></sec><sec id="sec3dot15-viruses-16-01893"><title>3.15. Publication Bias Analysis</title><p>A funnel plot was generated to assess potential publication bias among the included studies (<xref rid="app1-viruses-16-01893" ref-type="app">Figure S6</xref>). The plot reveals some asymmetry, especially in the lower half, where studies with smaller sample sizes and higher standard errors are scattered unevenly. This may indicate possible publication bias, as studies with lower HPV prevalence and smaller sample sizes appear under-represented in the analysis. Alternatively, the asymmetry could be influenced by study heterogeneity, including variations in populations, methodologies, or HPV genotype prevalence. Egger&#x02019;s test results further support this visual finding, with a statistically significant z-score of 1.9831 and a <italic toggle="yes">p</italic>-value of 0.0474, suggesting the presence of publication bias in the analysed studies.</p></sec><sec id="sec3dot16-viruses-16-01893"><title>3.16. Risk of Bias Assessment</title><p>The studies were grouped based on their design, and the risk of bias varied across these categories. Among cross-sectional and case-control studies (n = 64), 56% were assessed as having a low risk of bias, 41% as moderate risk, and 3% as high risk. For case-control studies specifically (n = 9), 56% were rated as low risk, 33% as moderate risk, and 11% as high risk. Cohort studies (n = 41) showed 42% with low risk, 51% with moderate risk, and 7% with high risk. In contrast, case series (n = 6) had the highest proportion of high-risk studies, with 50% rated as high risk, 33% as moderate risk, and only 17% as low risk.</p><p>Overall, across all included studies (n = 120), 49% (59/120) were rated as low risk, 42% (50/120) as moderate risk, and 9% (11/120) as high risk. This indicates that while most studies were of acceptable quality, nearly half had a moderate to high risk of bias, which could impact the reliability of the findings. Detailed risk of bias scores are provided in the <xref rid="app1-viruses-16-01893" ref-type="app">JBI Score table in the Supplementary Materials</xref>.</p></sec></sec><sec sec-type="discussion" id="sec4-viruses-16-01893"><title>4. Discussion</title><p>This systematic review and meta-analysis provide critical insights into HPV prevalence, genotype distribution, and its associations with cervicovaginal microbiota and cytokine profiles in South African women, particularly within the context of HIV status.</p><p>Our meta-analysis findings reveal a pooled HPV prevalence of 58% (95% CI: 52&#x02013;64%) among South African women, underscoring a substantial burden of infection. These results align with findings by Ogembo et al. [<xref rid="B155-viruses-16-01893" ref-type="bibr">155</xref>], who reported an HPV prevalence of 57.3% in Southern Africa, higher than other African regions, highlighting a significant infection rate in the region. Provincial prevalence rates ranged from 53% in KwaZulu-Natal and the Western Cape to 64% in Gauteng, with regional gaps in research (e.g., Mpumalanga, Northwest, Northern Cape, and Free State) limiting a full understanding of national patterns.</p><p>One of the most significant findings is the prevalence of HPV-35 (4.11%), which is disproportionately high in the African population compared to global data, where HPV-16 and -18 typically dominate. The increasing prevalence of HPV-35 among African populations, also reported by Bouassa et al. [<xref rid="B156-viruses-16-01893" ref-type="bibr">156</xref>] and Tchouaket et al. [<xref rid="B157-viruses-16-01893" ref-type="bibr">157</xref>], underscores a critical limitation in current HPV vaccine coverage, which primarily targets HPV-16 and -18. Expanding vaccine formulations to cover additional high-risk genotypes like HPV-35 could significantly enhance the effectiveness of HPV vaccination programmes across Africa, potentially reducing cervical cancer rates that remain disproportionately high in the region. These results call for global health organisations to consider more inclusive vaccine-development strategies that address diverse genotype distributions across populations. Among LR-HPV types, HPV-62 (5.80%) and HPV-84 (5.26%) were the most common, further reflecting the diversity of circulating HPV genotypes in South Africa.</p><p>Our study also examined HPV prevalence across various sample types, aiming for a broad view of the viral landscape. Cervical samples showed the highest prevalence (60%), followed by vaginal (53%), anal (42%), and oral samples (25%). The high prevalence in FGT samples, as compared to the URT, may reflect biological differences in HPV persistence and suggests the benefit of concurrent sampling from cervical and vaginal sites to capture the full scope of infection within the FGT. The lower prevalence and diversity of HPV in non-genital samples may also be due to reduced HPV viral loads or lower test sensitivity at these sites, as noted in previous studies [<xref rid="B158-viruses-16-01893" ref-type="bibr">158</xref>]. This highlights the need for future HPV genotyping research to better understand viral dynamics in non-genital locations, which contribute to broader transmission and potential oncogenesis.</p><p>The analysis also confirmed a higher pooled HPV prevalence (63%) in HIV-positive women compared to HIV-negative women (39%), consistent with global research linking HIV-associated immunosuppression to higher HPV acquisition and persistence rates [<xref rid="B123-viruses-16-01893" ref-type="bibr">123</xref>,<xref rid="B126-viruses-16-01893" ref-type="bibr">126</xref>,<xref rid="B159-viruses-16-01893" ref-type="bibr">159</xref>], yet the magnitude observed here calls for heightened integration of HPV and HIV prevention strategies in African contexts. Enhanced screening and treatment programs that address both HIV and HPV could improve outcomes for co-infected individuals and alleviate some of the public health burden linked to cervical cancer in Africa.</p><p>Given the high prevalence of HIV and HPV co-infection in Africa, understanding the role of the vaginal microbiota in modulating immune responses to these infections is essential for developing targeted screening and treatment strategies. The vaginal microbiota contains array of microorganisms that are crucial for both human health and the development of various diseases [<xref rid="B29-viruses-16-01893" ref-type="bibr">29</xref>]. Our findings reveal a shift from <italic toggle="yes">Lactobacillus</italic>-dominance to a more diverse, BV-associated microbiome in HPV-positive and HR-HPV-positive women, a pattern that echoes findings in other global populations. This suggests that a non-<italic toggle="yes">Lactobacillus</italic>-dominated environment may facilitate HPV persistence and potentially influence disease outcomes; however, the bidirectional influence of microbiota and disease progression requires further study. BV-associated species such as <italic toggle="yes">Atopobium</italic>, <italic toggle="yes">Aerococcus</italic>, <italic toggle="yes">Gardnerella</italic>, <italic toggle="yes">Sneathia</italic>, and <italic toggle="yes">Pseudomonas</italic> are potential biomarkers for HPV infections [<xref rid="B123-viruses-16-01893" ref-type="bibr">123</xref>], warranting further exploration as targets for therapeutic or probiotic interventions.</p><p>Distinct cytokine profiles linked to HPV, HIV, and BV status also highlight immune mechanisms that may influence infection persistence or clearance. Consistent with research on chronic HIV infection and elevated genital inflammatory cytokines [<xref rid="B160-viruses-16-01893" ref-type="bibr">160</xref>,<xref rid="B161-viruses-16-01893" ref-type="bibr">161</xref>]. HIV-positive women exhibited higher levels of IL-1&#x003b1;, MCP-1, and G-CSF, while IP-10, IL-6, and IL-8 were elevated in both HPV-positive and HIV-positive groups. The overlap of specific cytokines in HPV- and HIV-positive individuals suggests a shared inflammatory environment that could exacerbate HPV persistence in co-infected individuals. In contrast with other studies [<xref rid="B162-viruses-16-01893" ref-type="bibr">162</xref>,<xref rid="B163-viruses-16-01893" ref-type="bibr">163</xref>,<xref rid="B164-viruses-16-01893" ref-type="bibr">164</xref>], HPV-negative individuals showed lower levels of cytokines like IL-10 and IL-15, possibly reflecting a baseline immune environment with reduced inflammation. Notably, associations between BV-related bacteria and cytokines IL-1&#x003b2; and TNF-&#x003b1; in HPV-35-positive individuals highlight complex interactions between the microbiome and immune responses in HPV infection. In the broader context, these findings call attention to the potential for cytokine-based biomarkers to guide treatment strategies and enable early identification of women at risk for persistent infection or disease progression. Such biomarkers would be especially valuable in settings with limited access to advanced diagnostics.</p></sec><sec id="sec5-viruses-16-01893"><title>5. Limitations</title><p>Our review underscores the need for greater regional diversity in HPV research across South Africa, as many provinces remain understudied, leading to gaps in understanding HPV distribution at a national level. Future research should also focus on HPV prevalence in non-genital sites to improve understanding of broader transmission dynamics, especially considering oral HPV&#x02019;s emerging role in global HPV transmission patterns. Most of the included studies had a low to moderate risk of bias, indicating generally acceptable methodological quality. However, the observed risk of bias could have introduced variability, potentially affecting the robustness of the meta-analysis. This is supported by the asymmetry detected in the publication bias. Finally, addressing inconsistencies in microbiome and cytokine data reporting would facilitate more robust meta-analyses in future studies, enabling deeper insights into the biological interactions between HPV, the microbiome, and immune responses.</p></sec><sec sec-type="conclusions" id="sec6-viruses-16-01893"><title>6. Conclusions</title><p>In summary, this systematic review and meta-analysis highlights South Africa&#x02019;s high burden of HPV and its unique genotype distribution, with broader implications for vaccine development, screening practices, and integrative HPV- and HIV-prevention strategies. These findings contribute meaningfully to understanding HPV&#x02019;s public health impact in Southern Africa, where prevalence rates are notably high. When considered alongside studies from other regions of Africa, our results highlight a pressing need for tailored public health strategies, as the prevalence in Southern Africa exceeds that reported in other parts of the continent. This disparity reinforces the urgent need for region-specific approaches to HPV prevention, screening, and treatment. Additionally, these findings advocate for more inclusive vaccine coverage and underscore the importance of addressing microbial and immune factors in HPV research, particularly in African contexts. Addressing geographic and sample-type disparities in South African HPV research is essential for a more comprehensive understanding of infection patterns.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-viruses-16-01893"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/v16121893/s1">https://www.mdpi.com/article/10.3390/v16121893/s1</uri>, Figure S1: Forest plot showing the prevalence of HPV among women in various provinces of South Africa based on different studies. The random effects model estimated an overall prevalence with significant heterogeneity (I<sup>2</sup> = 99%, &#x003c4;<sup>2</sup> = 0.0917, <italic toggle="yes">p</italic> &#x0003c; 0.001). Subgroup analysis did not show significant differences in HPV prevalence between provinces (&#x003c7;<sup>2</sup> = 3.48, df = 4, <italic toggle="yes">p</italic> = 0.48); Figure S2: Prevalence of HPV among women based on different sample types. The random-effects model estimated an overall prevalence with significant heterogeneity (I<sup>2</sup> = 100%, &#x003c4;<sup>2</sup> = 0.1003, <italic toggle="yes">p</italic> &#x0003c; 0.001). Subgroup analysis revealed significant differences in HPV prevalence across sample types (&#x003c7;<sup>2</sup> = 514.15, df = 7, <italic toggle="yes">p</italic> &#x0003c; 0.01); Figure S3: Forest plot indicating the prevalence of HPV among South African women based on HIV status. The estimated prevalence from the random effects model showed a significant heterogeneity (I<sup>2</sup> = 99%, &#x003c4;<sup>2</sup> = 0.0821, <italic toggle="yes">p</italic> &#x0003c; 0.001); Figure S4: Prevalence (%) of HR-HPV genotypes detected in the FGT (A) and URT (B) samples from 1989 to 2024, and 2002 to 2020, respectively; Figure S5: Prevalence (%) of LR-HPV genotypes detected in the FGT (A) and URT (B) samples detected from 1991 to 2023, and 1991 to 2008, respectively; Figure S6: The funnel plot displaying the relationship between HPV prevalence (x-axis) and the standard error (y-axis) across the included studies assessing publication bias in HPV prevalence studies; Table S1: Reasons for excluding studies from the systematic review after reading full-text of the studies.</p><supplementary-material id="viruses-16-01893-s001" position="float" content-type="local-data"><media xlink:href="viruses-16-01893-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>N.D.M. conceived the study. N.D.M., P.P.M. and C.K.M. conducted the literature search and data extraction. N.D.M. and C.K.M. performed the publication bias. Data analyses was completed by N.D.M., P.P.M. and C.K.M. C.K.M. prepared the initial draft of the manuscript, which was subsequently reviewed and revised by N.D.M. and P.P.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01893"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okunade</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Human papillomavirus and cervical cancer</article-title><source>J. Obstet. Gynaecol.</source><year>2020</year><volume>40</volume><fpage>602</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1080/01443615.2019.1634030</pub-id><pub-id pub-id-type="pmid">31500479</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01893"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stuebs</surname><given-names>F.A.</given-names></name>
<name><surname>Gass</surname><given-names>P.</given-names></name>
<name><surname>Dietl</surname><given-names>A.K.</given-names></name>
<name><surname>Schulmeyer</surname><given-names>C.E.</given-names></name>
<name><surname>Adler</surname><given-names>W.</given-names></name>
<name><surname>Geppert</surname><given-names>C.</given-names></name>
<name><surname>Hartmann</surname><given-names>A.</given-names></name>
<name><surname>Kn&#x000f6;ll</surname><given-names>A.</given-names></name>
<name><surname>Beckmann</surname><given-names>M.W.</given-names></name>
<name><surname>Koch</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix</article-title><source>Arch. Gynecol. Obstet.</source><year>2021</year><volume>304</volume><fpage>751</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1007/s00404-021-05986-z</pub-id><pub-id pub-id-type="pmid">33538863</pub-id>
</element-citation></ref><ref id="B3-viruses-16-01893"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferlay</surname><given-names>J.</given-names></name>
<name><surname>Colombet</surname><given-names>M.</given-names></name>
<name><surname>Soerjomataram</surname><given-names>I.</given-names></name>
<name><surname>Parkin</surname><given-names>D.M.</given-names></name>
<name><surname>Pi&#x000f1;eros</surname><given-names>M.</given-names></name>
<name><surname>Znaor</surname><given-names>A.</given-names></name>
<name><surname>Bray</surname><given-names>F.</given-names></name>
</person-group><article-title>Cancer statistics for the year 2020: An overview</article-title><source>Int. J. Cancer</source><year>2021</year><volume>149</volume><fpage>778</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1002/ijc.33588</pub-id></element-citation></ref><ref id="B4-viruses-16-01893"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sung</surname><given-names>H.</given-names></name>
<name><surname>Ferlay</surname><given-names>J.</given-names></name>
<name><surname>Siegel</surname><given-names>R.L.</given-names></name>
<name><surname>Laversanne</surname><given-names>M.</given-names></name>
<name><surname>Soerjomataram</surname><given-names>I.</given-names></name>
<name><surname>Jemal</surname><given-names>A.</given-names></name>
<name><surname>Bray</surname><given-names>F.</given-names></name>
</person-group><article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA A Cancer J. Clin.</source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id></element-citation></ref><ref id="B5-viruses-16-01893"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jedy-Agba</surname><given-names>E.</given-names></name>
<name><surname>Joko</surname><given-names>W.Y.</given-names></name>
<name><surname>Liu</surname><given-names>B.</given-names></name>
<name><surname>Buziba</surname><given-names>N.G.</given-names></name>
<name><surname>Borok</surname><given-names>M.</given-names></name>
<name><surname>Korir</surname><given-names>A.</given-names></name>
<name><surname>Masamba</surname><given-names>L.</given-names></name>
<name><surname>Manraj</surname><given-names>S.S.</given-names></name>
<name><surname>Finesse</surname><given-names>A.</given-names></name>
<name><surname>Wabinga</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Trends in cervical cancer incidence in sub-Saharan Africa</article-title><source>Br. J. Cancer</source><year>2020</year><volume>123</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1038/s41416-020-0831-9</pub-id><pub-id pub-id-type="pmid">32336751</pub-id>
</element-citation></ref><ref id="B6-viruses-16-01893"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bogale</surname><given-names>A.L.</given-names></name>
<name><surname>Belay</surname><given-names>N.B.</given-names></name>
<name><surname>Medhin</surname><given-names>G.</given-names></name>
<name><surname>Ali</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: Systematic review and meta-analysis</article-title><source>Virol. J.</source><year>2020</year><volume>17</volume><elocation-id>179</elocation-id><pub-id pub-id-type="doi">10.1186/s12985-020-01448-1</pub-id><pub-id pub-id-type="pmid">33198743</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01893"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>M.A.</given-names></name>
<name><surname>Wentzensen</surname><given-names>N.</given-names></name>
</person-group><article-title>Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers</article-title><source>Cancer Cytopathol.</source><year>2018</year><volume>126</volume><fpage>447</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1002/cncy.22018</pub-id><pub-id pub-id-type="pmid">29797691</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01893"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Human papilloma virus in oral cancer</article-title><source>J. Korean Assoc. Oral Maxillofac. Surg.</source><year>2016</year><volume>42</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.5125/jkaoms.2016.42.6.327</pub-id><pub-id pub-id-type="pmid">28053902</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01893"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campisi</surname><given-names>G.</given-names></name>
<name><surname>Panzarella</surname><given-names>V.</given-names></name>
<name><surname>Giuliani</surname><given-names>M.</given-names></name>
<name><surname>Lajolo</surname><given-names>C.</given-names></name>
<name><surname>Di Fede</surname><given-names>O.</given-names></name>
<name><surname>Falaschini</surname><given-names>S.</given-names></name>
<name><surname>Di Liberto</surname><given-names>C.</given-names></name>
<name><surname>Scully</surname><given-names>C.</given-names></name>
<name><surname>Muzio</surname><given-names>L.L.</given-names></name>
</person-group><article-title>Human papillomavirus: Its identikit and controversial role in oral oncogenesis, premalignant and malignant lesions</article-title><source>Int. J. Oncol.</source><year>2007</year><volume>30</volume><fpage>813</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.3892/ijo.30.4.813</pub-id><pub-id pub-id-type="pmid">17332919</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01893"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Sanjos&#x000e9;</surname><given-names>S.</given-names></name>
<name><surname>Bruni</surname><given-names>L.</given-names></name>
<name><surname>Alemany</surname><given-names>L.</given-names></name>
</person-group><article-title>HPV in genital cancers (at the exception of cervical cancer) and anal cancers</article-title><source>La Presse M&#x000e9;dicale</source><year>2014</year><volume>43</volume><fpage>e423</fpage><lpage>e428</lpage><pub-id pub-id-type="doi">10.1016/j.lpm.2014.10.001</pub-id><pub-id pub-id-type="pmid">25455637</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01893"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moscicki</surname><given-names>A.-B.</given-names></name>
<name><surname>Darragh</surname><given-names>T.M.</given-names></name>
<name><surname>Berry-Lawhorn</surname><given-names>J.M.</given-names></name>
<name><surname>Roberts</surname><given-names>J.M.M.</given-names></name>
<name><surname>Khan</surname><given-names>M.J.</given-names></name>
<name><surname>Boardman</surname><given-names>L.A.M.</given-names></name>
<name><surname>Chiao</surname><given-names>E.</given-names></name>
<name><surname>Einstein</surname><given-names>M.H.M.</given-names></name>
<name><surname>Goldstone</surname><given-names>S.E.</given-names></name>
<name><surname>Jay</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Screening for anal cancer in women</article-title><source>J. Low. Genit. Tract Dis.</source><year>2015</year><volume>19</volume><fpage>S27</fpage><lpage>S42</lpage><pub-id pub-id-type="doi">10.1097/LGT.0000000000000117</pub-id><pub-id pub-id-type="pmid">26103446</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01893"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
<name><surname>Johnson</surname><given-names>L.F.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Risk factors for oral human papillomavirus in heterosexual couples in an African setting</article-title><source>J. Infect.</source><year>2013</year><volume>68</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2013.10.012</pub-id><pub-id pub-id-type="pmid">24184808</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01893"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parkin</surname><given-names>D.M.</given-names></name>
<name><surname>Bray</surname><given-names>F.</given-names></name>
</person-group><article-title>The burden of HPV-related cancers</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>S11</fpage><lpage>S25</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2006.05.111</pub-id><pub-id pub-id-type="pmid">16949997</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01893"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gillison</surname><given-names>M.L.</given-names></name>
<name><surname>Broutian</surname><given-names>T.</given-names></name>
<name><surname>Pickard</surname><given-names>R.K.L.</given-names></name>
<name><surname>Tong</surname><given-names>Z.-Y.</given-names></name>
<name><surname>Xiao</surname><given-names>W.</given-names></name>
<name><surname>Kahle</surname><given-names>L.</given-names></name>
<name><surname>Graubard</surname><given-names>B.I.</given-names></name>
<name><surname>Chaturvedi</surname><given-names>A.K.</given-names></name>
</person-group><article-title>Prevalence of oral HPV infection in the United States, 2009&#x02013;2010</article-title><source>JAMA</source><year>2012</year><volume>307</volume><fpage>693</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.101</pub-id><pub-id pub-id-type="pmid">22282321</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01893"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>W.-Q.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
</person-group><article-title>Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends</article-title><source>Gynecol. Oncol.</source><year>2021</year><volume>163</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2021.10.075</pub-id><pub-id pub-id-type="pmid">34688503</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01893"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>Q.</given-names></name>
<name><surname>Zeng</surname><given-names>X.</given-names></name>
<name><surname>Luo</surname><given-names>H.</given-names></name>
<name><surname>Pan</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Han</surname><given-names>N.</given-names></name>
</person-group><article-title>Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions</article-title><source>BMC Infect. Dis.</source><year>2023</year><volume>23</volume><elocation-id>667</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-023-08634-w</pub-id><pub-id pub-id-type="pmid">37805467</pub-id>
</element-citation></ref><ref id="B17-viruses-16-01893"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Trama</surname><given-names>J.P.</given-names></name>
<name><surname>Trikannad</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>J.J.</given-names></name>
<name><surname>Adelson</surname><given-names>M.E.</given-names></name>
<name><surname>Mordechai</surname><given-names>E.</given-names></name>
</person-group><article-title>High-risk HPV genotype distribution according to cervical cytology and age</article-title><source>Open Forum Infectious Diseases</source><publisher-name>Oxford University Press US</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2022</year><pub-id pub-id-type="doi">10.1093/ofid/ofac595</pub-id></element-citation></ref><ref id="B18-viruses-16-01893"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Gonz&#x000e1;lez</surname><given-names>A.</given-names></name>
<name><surname>Cachay</surname><given-names>E.</given-names></name>
<name><surname>Ocampo</surname><given-names>A.</given-names></name>
<name><surname>Poveda</surname><given-names>E.</given-names></name>
</person-group><article-title>Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><elocation-id>1047</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms10051047</pub-id><pub-id pub-id-type="pmid">35630489</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01893"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
<name><surname>Phohlo</surname><given-names>K.</given-names></name>
<name><surname>Garcia-Jardon</surname><given-names>M.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Businge</surname><given-names>C.B.</given-names></name>
</person-group><article-title>High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0264498</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0264498</pub-id><pub-id pub-id-type="pmid">35263376</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01893"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panwar</surname><given-names>K.</given-names></name>
<name><surname>Godi</surname><given-names>A.</given-names></name>
<name><surname>Cocuzza</surname><given-names>C.E.</given-names></name>
<name><surname>Andrews</surname><given-names>N.</given-names></name>
<name><surname>Southern</surname><given-names>J.</given-names></name>
<name><surname>Turner</surname><given-names>P.</given-names></name>
<name><surname>Miller</surname><given-names>E.</given-names></name>
<name><surname>Beddows</surname><given-names>S.</given-names></name>
</person-group><article-title>Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix<sup>&#x000ae;</sup> or Gardasil<sup>&#x000ae;</sup> vaccine</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><fpage>1198</fpage><lpage>1202</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.01.041</pub-id><pub-id pub-id-type="pmid">35115194</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01893"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Recent developments in human papillomavirus (HPV) vaccinology</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>1440</elocation-id><pub-id pub-id-type="doi">10.3390/v15071440</pub-id><pub-id pub-id-type="pmid">37515128</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01893"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Somdyala</surname><given-names>N.I.</given-names></name>
<name><surname>Mabunda</surname><given-names>S.A.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0253074</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0253074</pub-id><pub-id pub-id-type="pmid">34143816</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01893"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>R.</given-names></name>
</person-group><article-title>HPV vaccine: A breakthrough in prevention of cervical cancer</article-title><source>Apollo Med.</source><year>2012</year><volume>9</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.apme.2012.05.005</pub-id></element-citation></ref><ref id="B24-viruses-16-01893"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ntuli</surname><given-names>L.</given-names></name>
<name><surname>Mtshali</surname><given-names>A.</given-names></name>
<name><surname>Mzobe</surname><given-names>G.</given-names></name>
<name><surname>Liebenberg</surname><given-names>L.J.</given-names></name>
<name><surname>Ngcapu</surname><given-names>S.</given-names></name>
</person-group><article-title>Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2022</year><volume>12</volume><elocation-id>927131</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2022.927131</pub-id><pub-id pub-id-type="pmid">35873158</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01893"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Squillace</surname><given-names>N.</given-names></name>
<name><surname>Cogliandro</surname><given-names>V.</given-names></name>
<name><surname>Ranzani</surname><given-names>A.</given-names></name>
<name><surname>Bana</surname><given-names>N.B.</given-names></name>
<name><surname>Bonfanti</surname><given-names>P.</given-names></name>
</person-group><article-title>Human Papilloma Virus Related Cancers in People Living with HIV</article-title><source>Current Infectious Dis. Rep.</source><year>2023</year><volume>25</volume><fpage>151</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1007/s11908-023-00808-6</pub-id></element-citation></ref><ref id="B26-viruses-16-01893"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gyane</surname><given-names>F.A.</given-names></name>
<name><surname>Modey</surname><given-names>E.</given-names></name>
<name><surname>Maya</surname><given-names>E.</given-names></name>
<name><surname>Bonney</surname><given-names>E.Y.</given-names></name>
<name><surname>Abaidoo-Myles</surname><given-names>A.</given-names></name>
<name><surname>Paintsil</surname><given-names>E.</given-names></name>
<name><surname>Torpey</surname><given-names>K.</given-names></name>
</person-group><article-title>Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0303535</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0303535</pub-id><pub-id pub-id-type="pmid">38814956</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01893"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Mondatore</surname><given-names>D.</given-names></name>
<name><surname>Bai</surname><given-names>F.</given-names></name>
<name><surname>Augello</surname><given-names>M.</given-names></name>
<name><surname>Giovenzana</surname><given-names>M.</given-names></name>
<name><surname>Ceretti</surname><given-names>A.P.</given-names></name>
<name><surname>Bono</surname><given-names>V.</given-names></name>
<name><surname>Opocher</surname><given-names>E.</given-names></name>
<name><surname>Monforte</surname><given-names>A.D.</given-names></name>
<name><surname>Marchetti</surname><given-names>G.C.</given-names></name>
<name><surname>Tincati</surname><given-names>C.</given-names></name>
</person-group><article-title>Persistence of high percentage of peripheral activated CD8+ T cells predict cytologic HPV-related dysplasia in cART-Treated, HIV-Positive Subjects</article-title><source>Open Forum Infectious Diseases</source><publisher-name>Oxford University Press US</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2022</year><pub-id pub-id-type="doi">10.1093/ofid/ofac046</pub-id></element-citation></ref><ref id="B28-viruses-16-01893"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gardella</surname><given-names>B.</given-names></name>
<name><surname>Pasquali</surname><given-names>M.F.</given-names></name>
<name><surname>La Verde</surname><given-names>M.</given-names></name>
<name><surname>Cianci</surname><given-names>S.</given-names></name>
<name><surname>Torella</surname><given-names>M.</given-names></name>
<name><surname>Dominoni</surname><given-names>M.</given-names></name>
</person-group><article-title>The complex interplay between vaginal microbiota, HPV infection, and immunological microenvironment in cervical intraepithelial neoplasia: A literature review</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>7174</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23137174</pub-id><pub-id pub-id-type="pmid">35806188</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01893"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Su</surname><given-names>M.</given-names></name>
<name><surname>Diao</surname><given-names>X.</given-names></name>
<name><surname>Liang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Zhan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Characteristics of vaginal microbiota in various cervical intraepithelial neoplasia: A cross-sectional study</article-title><source>J. Transl. Med.</source><year>2023</year><volume>21</volume><elocation-id>816</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-023-04676-5</pub-id><pub-id pub-id-type="pmid">37974192</pub-id>
</element-citation></ref><ref id="B30-viruses-16-01893"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alimena</surname><given-names>S.</given-names></name>
<name><surname>Davis</surname><given-names>J.</given-names></name>
<name><surname>Fichorova</surname><given-names>R.N.</given-names></name>
<name><surname>Feldman</surname><given-names>S.</given-names></name>
</person-group><article-title>The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer</article-title><source>Curr. Probl. Cancer</source><year>2022</year><volume>46</volume><elocation-id>100877</elocation-id><pub-id pub-id-type="doi">10.1016/j.currproblcancer.2022.100877</pub-id><pub-id pub-id-type="pmid">35709613</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01893"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qingqing</surname><given-names>B.</given-names></name>
<name><surname>Jie</surname><given-names>Z.</given-names></name>
<name><surname>Songben</surname><given-names>Q.</given-names></name>
<name><surname>Juan</surname><given-names>C.</given-names></name>
<name><surname>Lei</surname><given-names>Z.</given-names></name>
<name><surname>Mu</surname><given-names>X.</given-names></name>
</person-group><article-title>Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection</article-title><source>Microb. Pathog.</source><year>2020</year><volume>152</volume><elocation-id>104617</elocation-id><pub-id pub-id-type="doi">10.1016/j.micpath.2020.104617</pub-id><pub-id pub-id-type="pmid">33207260</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01893"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez-Filloy</surname><given-names>M.</given-names></name>
<name><surname>Cortez</surname><given-names>F.J.</given-names></name>
<name><surname>Gheit</surname><given-names>T.</given-names></name>
<name><surname>Cruz</surname><given-names>O.C.Y.</given-names></name>
<name><surname>Cruz-Talonia</surname><given-names>F.</given-names></name>
<name><surname>Ch&#x000e1;vez-Torres</surname><given-names>M.</given-names></name>
<name><surname>Arteaga-G&#x000f3;mez</surname><given-names>C.</given-names></name>
<name><surname>Mancilla-Herrera</surname><given-names>I.</given-names></name>
<name><surname>Montesinos</surname><given-names>J.J.</given-names></name>
<name><surname>Cort&#x000e9;s-Morales</surname><given-names>V.A.</given-names></name>
<etal/>
</person-group><article-title>Altered vaginal microbiota composition correlates with human papillomavirus and mucosal immune responses in women with symptomatic cervical ectopy</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2022</year><volume>12</volume><elocation-id>884272</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2022.884272</pub-id><pub-id pub-id-type="pmid">35656032</pub-id>
</element-citation></ref><ref id="B33-viruses-16-01893"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x00141;aniewski</surname><given-names>P.</given-names></name>
<name><surname>Cui</surname><given-names>H.</given-names></name>
<name><surname>Roe</surname><given-names>D.J.</given-names></name>
<name><surname>Chase</surname><given-names>D.M.</given-names></name>
<name><surname>Herbst-Kralovetz</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment</article-title><source>npj Precis. Oncol.</source><year>2020</year><volume>4</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1038/s41698-020-0126-x</pub-id><pub-id pub-id-type="pmid">32802959</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01893"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id></element-citation></ref><ref id="B35-viruses-16-01893"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Munn</surname><given-names>Z.</given-names></name>
<name><surname>Moola</surname><given-names>S.</given-names></name>
<name><surname>Lisy</surname><given-names>K.</given-names></name>
<name><surname>Riitano</surname><given-names>D.</given-names></name>
<name><surname>Tufanaru</surname><given-names>C.</given-names></name>
</person-group><article-title>Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data</article-title><source>JBI Evid. Implement.</source><year>2015</year><volume>13</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1097/XEB.0000000000000054</pub-id></element-citation></ref><ref id="B36-viruses-16-01893"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>J.P.T.</given-names></name>
<name><surname>Thomas</surname><given-names>J.</given-names></name>
<name><surname>Chandler</surname><given-names>J.</given-names></name>
<name><surname>Cumpston</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>Welch</surname><given-names>V.A.</given-names></name>
</person-group><source>Cochrane Handbook for Systematic Reviews of Interventions</source><publisher-name>Wiley</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2019</year></element-citation></ref><ref id="B37-viruses-16-01893"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>J.P.T.</given-names></name>
<name><surname>Thompson</surname><given-names>S.G.</given-names></name>
<name><surname>Deeks</surname><given-names>J.J.</given-names></name>
<name><surname>Altman</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id>
</element-citation></ref><ref id="B38-viruses-16-01893"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Dehaeck</surname><given-names>C.M.C.</given-names></name>
<name><surname>Soeters</surname><given-names>R.</given-names></name>
</person-group><article-title>Typing of human papillomaviruses in cervical intraepithelial neoplasia grade 3 biopsies from Cape Town</article-title><source>J. Med. Virol.</source><year>1989</year><volume>28</volume><fpage>146</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890280307</pub-id><pub-id pub-id-type="pmid">2547018</pub-id>
</element-citation></ref><ref id="B39-viruses-16-01893"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>K.</given-names></name>
<name><surname>Herrington</surname><given-names>C.S.</given-names></name>
<name><surname>Graham</surname><given-names>A.K.</given-names></name>
<name><surname>Evans</surname><given-names>M.F.</given-names></name>
<name><surname>O&#x02019;McGee</surname><given-names>J.</given-names></name>
</person-group><article-title>In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa</article-title><source>J. Clin. Pathol.</source><year>1991</year><volume>44</volume><fpage>406</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1136/jcp.44.5.406</pub-id><pub-id pub-id-type="pmid">1646238</pub-id>
</element-citation></ref><ref id="B40-viruses-16-01893"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>K.</given-names></name>
<name><surname>Herrington</surname><given-names>C.S.</given-names></name>
<name><surname>Graham</surname><given-names>A.K.</given-names></name>
<name><surname>Evans</surname><given-names>M.F.</given-names></name>
<name><surname>McGee</surname><given-names>J.O.</given-names></name>
</person-group><article-title>In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: Evidence for putative HPV integration in vivo</article-title><source>J. Clin. Pathol.</source><year>1991</year><volume>44</volume><fpage>400</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1136/jcp.44.5.400</pub-id><pub-id pub-id-type="pmid">1646237</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01893"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>J.E.</given-names></name>
<name><surname>Dehaeck</surname><given-names>C.M.C.</given-names></name>
<name><surname>Soeters</surname><given-names>R.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Typing and molecular characterization of human papillomaviruses in genital warts from South African women</article-title><source>J. Med. Virol.</source><year>1991</year><volume>33</volume><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890330108</pub-id><pub-id pub-id-type="pmid">1849982</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01893"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padayachee</surname><given-names>A.</given-names></name>
<name><surname>van Wyk</surname><given-names>C.W.</given-names></name>
</person-group><article-title>Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization</article-title><source>J. Oral Pathol. Med.</source><year>1991</year><volume>20</volume><fpage>210</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0714.1991.tb00420.x</pub-id><pub-id pub-id-type="pmid">1648613</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01893"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>K.</given-names></name>
<name><surname>Herrington</surname><given-names>C.S.</given-names></name>
<name><surname>Lo</surname><given-names>E.S.</given-names></name>
<name><surname>Evans</surname><given-names>M.F.</given-names></name>
<name><surname>O&#x02019;McGee</surname><given-names>J.</given-names></name>
</person-group><article-title>Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma</article-title><source>J. Clin. Pathol.</source><year>1992</year><volume>45</volume><fpage>382</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1136/jcp.45.5.382</pub-id><pub-id pub-id-type="pmid">1317883</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01893"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padayachee</surname><given-names>A.</given-names></name>
<name><surname>Prescott</surname><given-names>C.</given-names></name>
</person-group><article-title>Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children&#x02019;s Hospital Experience 1982&#x02013;1988</article-title><source>Int. J. Pediatr. Otorhinolaryngol.</source><year>1993</year><volume>26</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/0165-5876(93)90019-Y</pub-id><pub-id pub-id-type="pmid">8383099</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01893"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Brink</surname><given-names>N.S.</given-names></name>
<name><surname>Dehaeck</surname><given-names>C.M.C.</given-names></name>
<name><surname>Ovens</surname><given-names>S.</given-names></name>
<name><surname>Soeters</surname><given-names>R.</given-names></name>
<name><surname>Rybicki</surname><given-names>E.P.</given-names></name>
</person-group><article-title>Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town</article-title><source>J. Med. Virol.</source><year>1994</year><volume>43</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890430307</pub-id><pub-id pub-id-type="pmid">7931183</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01893"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wright</surname><given-names>C.A.</given-names></name>
<name><surname>Taylor</surname><given-names>L.</given-names></name>
<name><surname>Cooper</surname><given-names>K.</given-names></name>
</person-group><article-title>HPV typing of vulvovaginal condylomata in children</article-title><source>S. Afr. Med. J. Suid-Afr. Tydskr. Vir Geneeskd.</source><year>1995</year><volume>85</volume><issue>(Suppl. S10)</issue><fpage>1096</fpage><lpage>1101</lpage></element-citation></ref><ref id="B47-viruses-16-01893"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grayson</surname><given-names>W.</given-names></name>
<name><surname>Taylor</surname><given-names>L.</given-names></name>
<name><surname>Cooper</surname><given-names>K.</given-names></name>
</person-group><article-title>Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix</article-title><source>J. Clin. Pathol.</source><year>1996</year><volume>49</volume><fpage>805</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1136/jcp.49.10.805</pub-id><pub-id pub-id-type="pmid">8943745</pub-id>
</element-citation></ref><ref id="B48-viruses-16-01893"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramesar</surname><given-names>J.E.</given-names></name>
<name><surname>Dehaeck</surname><given-names>C.M.</given-names></name>
<name><surname>Soeters</surname><given-names>R.</given-names></name>
<name><surname>Williamson</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Human papillomavirus in normal cervical smears from Cape Town</article-title><source>S. Afr. Med. J.</source><year>1996</year><volume>86</volume><fpage>1402</fpage><lpage>1405</lpage><pub-id pub-id-type="pmid">8980559</pub-id>
</element-citation></ref><ref id="B49-viruses-16-01893"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chetty</surname><given-names>R.</given-names></name>
<name><surname>Bramdev</surname><given-names>A.</given-names></name>
<name><surname>Aguirre-Arteta</surname><given-names>A.</given-names></name>
<name><surname>Pegoraro</surname><given-names>R.J.</given-names></name>
<name><surname>Sataar</surname><given-names>N.</given-names></name>
</person-group><article-title>Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix</article-title><source>J. Clin. Pathol.</source><year>1997</year><volume>50</volume><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1136/jcp.50.5.413</pub-id><pub-id pub-id-type="pmid">9215125</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01893"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Risi</surname><given-names>L.</given-names></name>
<name><surname>Richart</surname><given-names>R.M.</given-names></name>
<name><surname>Pollack</surname><given-names>A.</given-names></name>
<name><surname>Lorincz</surname><given-names>A.</given-names></name>
<name><surname>Kostecki</surname><given-names>F.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Two-stage cervical cancer screening: An alternative for resource-poor settings</article-title><source>Am. J. Obstet. Gynecol.</source><year>2000</year><volume>183</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1067/mob.2000.105871</pub-id><pub-id pub-id-type="pmid">10942474</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01893"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Pollack</surname><given-names>A.</given-names></name>
<name><surname>Lorincz</surname><given-names>A.</given-names></name>
<name><surname>Richart</surname><given-names>R.M.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Human papillomavirus DNA testing for cervical cancer screening in low-resource settings</article-title><source>JNCI J. Natl. Cancer Inst.</source><year>2000</year><volume>92</volume><fpage>818</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1093/jnci/92.10.818</pub-id><pub-id pub-id-type="pmid">10814677</pub-id>
</element-citation></ref><ref id="B52-viruses-16-01893"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wright</surname><given-names>T.C.</given-names><suffix>Jr.</suffix></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Pollack</surname><given-names>A.</given-names></name>
<name><surname>Lorincz</surname><given-names>A.</given-names></name>
</person-group><article-title>HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer</article-title><source>JAMA</source><year>2000</year><volume>283</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1001/jama.283.1.81</pub-id><pub-id pub-id-type="pmid">10632284</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01893"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kay</surname><given-names>P.</given-names></name>
<name><surname>Meehan</surname><given-names>K.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA</article-title><source>J. Virol. Methods</source><year>2002</year><volume>105</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/S0166-0934(02)00100-3</pub-id><pub-id pub-id-type="pmid">12176153</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01893"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Passmore</surname><given-names>J.S.</given-names></name>
<name><surname>Burch</surname><given-names>V.C.</given-names></name>
<name><surname>Shephard</surname><given-names>E.G.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Kay</surname><given-names>P.</given-names></name>
<name><surname>Rose</surname><given-names>R.C.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV</article-title><source>J. Med. Virol.</source><year>2002</year><volume>67</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1002/jmv.2212</pub-id><pub-id pub-id-type="pmid">11992584</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01893"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kay</surname><given-names>P.</given-names></name>
<name><surname>Soeters</surname><given-names>R.</given-names></name>
<name><surname>Nevin</surname><given-names>J.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Dehaeck</surname><given-names>C.M.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia</article-title><source>J. Med. Virol.</source><year>2003</year><volume>71</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1002/jmv.10479</pub-id><pub-id pub-id-type="pmid">12938202</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01893"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kay</surname><given-names>P.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer</article-title><source>J. Med. Virol.</source><year>2005</year><volume>75</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1002/jmv.20294</pub-id><pub-id pub-id-type="pmid">15648077</pub-id>
</element-citation></ref><ref id="B57-viruses-16-01893"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allan</surname><given-names>B.R.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Shapiro</surname><given-names>S.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus</article-title><source>S. Afr. Med. J.</source><year>2006</year><volume>96</volume><fpage>1186</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">17167705</pub-id>
</element-citation></ref><ref id="B58-viruses-16-01893"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boy</surname><given-names>S.</given-names></name>
<name><surname>Van Rensburg</surname><given-names>E.J.</given-names></name>
<name><surname>Engelbrecht</surname><given-names>S.</given-names></name>
<name><surname>Dreyer</surname><given-names>L.</given-names></name>
<name><surname>van Heerden</surname><given-names>M.</given-names></name>
<name><surname>van Heerden</surname><given-names>W.</given-names></name>
</person-group><article-title>HPV detection in primary intra-oral squamous cell carcinomas&#x02014;Commensal, aetiological agent or contamination?</article-title><source>J. Oral Pathol. Med.</source><year>2006</year><volume>35</volume><fpage>86</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0714.2006.00385.x</pub-id><pub-id pub-id-type="pmid">16430738</pub-id>
</element-citation></ref><ref id="B59-viruses-16-01893"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Passmore</surname><given-names>J.S.</given-names></name>
<name><surname>Milner</surname><given-names>M.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Sampson</surname><given-names>C.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Gumbi</surname><given-names>P.P.</given-names></name>
<name><surname>Hitzeroth</surname><given-names>I.I.</given-names></name>
<name><surname>Rybicki</surname><given-names>E.P.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia</article-title><source>Immunology</source><year>2006</year><volume>119</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2006.02465.x</pub-id><pub-id pub-id-type="pmid">17026720</pub-id>
</element-citation></ref><ref id="B60-viruses-16-01893"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>H.E.</given-names></name>
<name><surname>Allan</surname><given-names>B.R.</given-names></name>
<name><surname>van de Wijgert</surname><given-names>J.H.H.M.</given-names></name>
<name><surname>Altini</surname><given-names>L.</given-names></name>
<name><surname>Taylor</surname><given-names>S.M.</given-names></name>
<name><surname>de Kock</surname><given-names>A.</given-names></name>
<name><surname>Coetzee</surname><given-names>N.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa</article-title><source>J. Clin. Microbiol.</source><year>2007</year><volume>45</volume><fpage>1679</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1128/JCM.02369-06</pub-id><pub-id pub-id-type="pmid">17409209</pub-id>
</element-citation></ref><ref id="B61-viruses-16-01893"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Passmore</surname><given-names>J.S.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Sampson</surname><given-names>C.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Parker</surname><given-names>N.</given-names></name>
<name><surname>Milner</surname><given-names>M.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia</article-title><source>J. Med. Virol.</source><year>2007</year><volume>79</volume><fpage>1375</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1002/jmv.20901</pub-id><pub-id pub-id-type="pmid">17607771</pub-id>
</element-citation></ref><ref id="B62-viruses-16-01893"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Shapiro</surname><given-names>S.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Cervical human papillomavirus (HPV) infection in South African women: Implications for HPV screening and vaccine strategies</article-title><source>J. Clin. Microbiol.</source><year>2008</year><volume>46</volume><fpage>740</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1128/JCM.01981-07</pub-id><pub-id pub-id-type="pmid">17977997</pub-id>
</element-citation></ref><ref id="B63-viruses-16-01893"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Boa</surname><given-names>R.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Hardie</surname><given-names>D.</given-names></name>
<name><surname>Stan</surname><given-names>R.</given-names></name>
<name><surname>Myer</surname><given-names>L.</given-names></name>
</person-group><article-title>Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women</article-title><source>Obstet. Gynecol.</source><year>2008</year><volume>111</volume><fpage>1380</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1097/AOG.0b013e3181743327</pub-id><pub-id pub-id-type="pmid">18515522</pub-id>
</element-citation></ref><ref id="B64-viruses-16-01893"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Passmore</surname><given-names>J.S.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Sampson</surname><given-names>C.</given-names></name>
<name><surname>Allan</surname><given-names>B.R.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa</article-title><source>J. Med. Virol.</source><year>2008</year><volume>80</volume><fpage>953</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1002/jmv.21166</pub-id><pub-id pub-id-type="pmid">18428143</pub-id>
</element-citation></ref><ref id="B65-viruses-16-01893"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Constant</surname><given-names>D.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Carrara</surname><given-names>H.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Shapiro</surname><given-names>S.</given-names></name>
<name><surname>Morroni</surname><given-names>C.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women</article-title><source>J. Clin. Microbiol.</source><year>2008</year><volume>46</volume><fpage>732</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1128/JCM.01322-07</pub-id><pub-id pub-id-type="pmid">18077644</pub-id>
</element-citation></ref><ref id="B66-viruses-16-01893"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Richter</surname><given-names>K.L.</given-names></name>
<name><surname>Van Rensburg</surname><given-names>E.J.</given-names></name>
<name><surname>Van Heerden</surname><given-names>W.F.P.</given-names></name>
<name><surname>Boy</surname><given-names>S.C.</given-names></name>
</person-group><article-title>Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy</article-title><source>J. Oral Pathol. Med.</source><year>2008</year><volume>37</volume><fpage>555</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0714.2008.00670.x</pub-id><pub-id pub-id-type="pmid">18355174</pub-id>
</element-citation></ref><ref id="B67-viruses-16-01893"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Firnhaber</surname><given-names>C.</given-names></name>
<name><surname>Zungu</surname><given-names>K.</given-names></name>
<name><surname>Levin</surname><given-names>S.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Montaner</surname><given-names>L.J.</given-names></name>
<name><surname>McPhail</surname><given-names>P.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Allan</surname><given-names>B.R.</given-names></name>
<name><surname>Van der Horst</surname><given-names>C.</given-names></name>
<name><surname>Rinas</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa</article-title><source>Acta Cytol.</source><year>2009</year><volume>53</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1159/000325079</pub-id><pub-id pub-id-type="pmid">19248549</pub-id>
</element-citation></ref><ref id="B68-viruses-16-01893"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Kamupira</surname><given-names>M.</given-names></name>
<name><surname>Zwane</surname><given-names>E.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Constant</surname><given-names>D.</given-names></name>
<name><surname>Moodley</surname><given-names>J.R.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
</person-group><article-title>Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection</article-title><source>J. Infect. Dis.</source><year>2009</year><volume>199</volume><fpage>1514</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1086/598220</pub-id><pub-id pub-id-type="pmid">19392625</pub-id>
</element-citation></ref><ref id="B69-viruses-16-01893"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moodley</surname><given-names>J.R.</given-names></name>
<name><surname>Constant</surname><given-names>D.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Salimo</surname><given-names>A.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Rybicki</surname><given-names>E.</given-names></name>
<name><surname>Hitzeroth</surname><given-names>I.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: A cross-sectional study</article-title><source>BMC Cancer</source><year>2009</year><volume>9</volume><elocation-id>275</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2407-9-275</pub-id><pub-id pub-id-type="pmid">19664216</pub-id>
</element-citation></ref><ref id="B70-viruses-16-01893"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Said</surname><given-names>H.</given-names></name>
<name><surname>Ahmed</surname><given-names>K.</given-names></name>
<name><surname>Burnett</surname><given-names>R.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Hoosen</surname><given-names>A.</given-names></name>
</person-group><article-title>HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa</article-title><source>J. Clin. Virol.</source><year>2009</year><volume>44</volume><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2009.02.001</pub-id><pub-id pub-id-type="pmid">19269889</pub-id>
</element-citation></ref><ref id="B71-viruses-16-01893"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Hu</surname><given-names>C.-C.</given-names></name>
<name><surname>Tsai</surname><given-names>W.-Y.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Human papillomavirus-based cervical cancer prevention: Long-term results of a randomized screening trial</article-title><source>JNCI J. Natl. Cancer Inst.</source><year>2010</year><volume>102</volume><fpage>1557</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1093/jnci/djq342</pub-id><pub-id pub-id-type="pmid">20884893</pub-id>
</element-citation></ref><ref id="B72-viruses-16-01893"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Firnhaber</surname><given-names>C.</given-names></name>
<name><surname>Van Le</surname><given-names>H.</given-names></name>
<name><surname>Pettifor</surname><given-names>A.</given-names></name>
<name><surname>Schulze</surname><given-names>D.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Sanne</surname><given-names>I.M.</given-names></name>
<name><surname>Lewis</surname><given-names>D.A.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Williams</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa</article-title><source>Cancer Causes Control</source><year>2010</year><volume>21</volume><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1007/s10552-009-9475-z</pub-id><pub-id pub-id-type="pmid">19949850</pub-id>
</element-citation></ref><ref id="B73-viruses-16-01893"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Tsai</surname><given-names>W.-Y.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
</person-group><article-title>Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected womens</article-title><source>AIDS</source><year>2010</year><volume>24</volume><fpage>2553</fpage><lpage>2561</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e32833e163e</pub-id><pub-id pub-id-type="pmid">20706107</pub-id>
</element-citation></ref><ref id="B74-viruses-16-01893"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Johnson</surname><given-names>L.F.</given-names></name>
<name><surname>Boulle</surname><given-names>A.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples</article-title><source>J. Gen. Virol.</source><year>2010</year><volume>91</volume><fpage>3023</fpage><lpage>3031</lpage><pub-id pub-id-type="doi">10.1099/vir.0.020669-0</pub-id><pub-id pub-id-type="pmid">20719990</pub-id>
</element-citation></ref><ref id="B75-viruses-16-01893"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moodley</surname><given-names>M.</given-names></name>
<name><surname>Lindeque</surname><given-names>G.</given-names></name>
<name><surname>Connolly</surname><given-names>C.</given-names></name>
</person-group><article-title>Human papillomavirus (HPV)-type distribution in relation to oral contraceptive use in women with cervical intraepithelial neoplasia, Durban, South Africa</article-title><source>Eur. J. Gynaecol. Oncol.</source><year>2010</year><volume>31</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">21077468</pub-id>
</element-citation></ref><ref id="B76-viruses-16-01893"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Tsai</surname><given-names>W.-Y.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
</person-group><article-title>Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: Results from a randomized trial in South Africa</article-title><source>BMC Med.</source><year>2010</year><volume>8</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7015-8-40</pub-id><pub-id pub-id-type="pmid">20587028</pub-id>
</element-citation></ref><ref id="B77-viruses-16-01893"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Auvert</surname><given-names>B.</given-names></name>
<name><surname>Marais</surname><given-names>D.</given-names></name>
<name><surname>Lissouba</surname><given-names>P.</given-names></name>
<name><surname>Zarca</surname><given-names>K.</given-names></name>
<name><surname>Ramjee</surname><given-names>G.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers</article-title><source>Infect. Dis. Obstet. Gynecol.</source><year>2011</year><volume>2011</volume><elocation-id>692012</elocation-id><pub-id pub-id-type="doi">10.1155/2011/692012</pub-id><pub-id pub-id-type="pmid">21804752</pub-id>
</element-citation></ref><ref id="B78-viruses-16-01893"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Firnhaber</surname><given-names>C.</given-names></name>
<name><surname>Evans</surname><given-names>D.</given-names></name>
<name><surname>Friedman-Khalili</surname><given-names>R.</given-names></name>
<name><surname>Willliams</surname><given-names>S.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Matlhagela</surname><given-names>K.</given-names></name>
<name><surname>Wester</surname><given-names>C.</given-names></name>
<name><surname>Grinsztejn</surname><given-names>B.</given-names></name>
<name><surname>Lockman</surname><given-names>S.</given-names></name>
</person-group><article-title>Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana</article-title><source>J. Clin. Virol.</source><year>2011</year><volume>52</volume><fpage>265</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2011.08.011</pub-id><pub-id pub-id-type="pmid">21908233</pub-id>
</element-citation></ref><ref id="B79-viruses-16-01893"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taylor</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
</person-group><article-title>A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat</article-title><source>Int. J. Cancer</source><year>2011</year><volume>129</volume><fpage>879</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1002/ijc.25731</pub-id><pub-id pub-id-type="pmid">20957631</pub-id>
</element-citation></ref><ref id="B80-viruses-16-01893"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
</person-group><article-title>Rapid Rise in Detection of Human Papillomavirus (HPV) Infection Soon After Incident HIV Infection Among South African Women</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>203</volume><fpage>479</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiq083</pub-id><pub-id pub-id-type="pmid">21216869</pub-id>
</element-citation></ref><ref id="B81-viruses-16-01893"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Vuyst</surname><given-names>H.</given-names></name>
<name><surname>Ndirangu</surname><given-names>G.</given-names></name>
<name><surname>Moodley</surname><given-names>M.</given-names></name>
<name><surname>Tenet</surname><given-names>V.</given-names></name>
<name><surname>Estambale</surname><given-names>B.</given-names></name>
<name><surname>Meijer</surname><given-names>C.J.</given-names></name>
<name><surname>Snijders</surname><given-names>P.J.</given-names></name>
<name><surname>Clifford</surname><given-names>G.</given-names></name>
<name><surname>Franceschi</surname><given-names>S.</given-names></name>
</person-group><article-title>Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa</article-title><source>Int. J. Cancer</source><year>2011</year><volume>131</volume><fpage>949</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1002/ijc.26470</pub-id><pub-id pub-id-type="pmid">21960453</pub-id>
</element-citation></ref><ref id="B82-viruses-16-01893"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dols</surname><given-names>J.A.</given-names></name>
<name><surname>Reid</surname><given-names>G.</given-names></name>
<name><surname>Kort</surname><given-names>R.</given-names></name>
<name><surname>Schuren</surname><given-names>F.H.</given-names></name>
<name><surname>Tempelman</surname><given-names>H.</given-names></name>
<name><surname>Bontekoe</surname><given-names>T.R.</given-names></name>
<name><surname>Korporaal</surname><given-names>H.</given-names></name>
<name><surname>Van der Veer</surname><given-names>E.</given-names></name>
<name><surname>Smit</surname><given-names>P.W.</given-names></name>
<name><surname>Boon</surname><given-names>M.E.</given-names></name>
</person-group><article-title>PCR-based identification of eight lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of south african women at risk of HIV and BV</article-title><source>Diagn. Cytopathol.</source><year>2011</year><volume>40</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1002/dc.21786</pub-id><pub-id pub-id-type="pmid">22021225</pub-id>
</element-citation></ref><ref id="B83-viruses-16-01893"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Marais</surname><given-names>D.J.</given-names></name>
<name><surname>Johnson</surname><given-names>L.F.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis299</pub-id><pub-id pub-id-type="pmid">22517913</pub-id>
</element-citation></ref><ref id="B84-viruses-16-01893"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDonald</surname><given-names>A.C.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Tsai</surname><given-names>W.-Y.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
</person-group><article-title>Distribution of High-Risk Human Papillomavirus Genotypes among HIV-Negative Women with and without Cervical Intraepithelial Neoplasia in South Africa</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e44332</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044332</pub-id><pub-id pub-id-type="pmid">22970201</pub-id>
</element-citation></ref><ref id="B85-viruses-16-01893"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Salimo</surname><given-names>A.T.</given-names></name>
<name><surname>Coetzee</surname><given-names>B.</given-names></name>
<name><surname>Maree</surname><given-names>H.J.</given-names></name>
<name><surname>Moodley</surname><given-names>J.</given-names></name>
<name><surname>Hitzeroth</surname><given-names>I.I.</given-names></name>
<name><surname>Freeborough</surname><given-names>M.-J.</given-names></name>
<name><surname>Rybicki</surname><given-names>E.P.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits</article-title><source>Virol. J.</source><year>2012</year><volume>9</volume><elocation-id>164</elocation-id><pub-id pub-id-type="doi">10.1186/1743-422X-9-164</pub-id><pub-id pub-id-type="pmid">22897914</pub-id>
</element-citation></ref><ref id="B86-viruses-16-01893"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bere</surname><given-names>A.</given-names></name>
<name><surname>Tayib</surname><given-names>S.</given-names></name>
<name><surname>Kriek</surname><given-names>J.-M.</given-names></name>
<name><surname>Masson</surname><given-names>L.</given-names></name>
<name><surname>Jaumdally</surname><given-names>S.Z.</given-names></name>
<name><surname>Barnabas</surname><given-names>S.L.</given-names></name>
<name><surname>Carr</surname><given-names>W.H.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Altered phenotype and function of NK cells infiltrating Human Papillomavirus (HPV)-associated genital warts during HIV infection</article-title><source>Clin. Immunol.</source><year>2013</year><volume>150</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2013.12.005</pub-id><pub-id pub-id-type="pmid">24440646</pub-id>
</element-citation></ref><ref id="B87-viruses-16-01893"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Magooa</surname><given-names>M.P.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Djigma</surname><given-names>F.</given-names></name>
<name><surname>Didelot</surname><given-names>M.-N.</given-names></name>
<name><surname>Kelly</surname><given-names>H.</given-names></name>
<name><surname>Yonli</surname><given-names>A.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<name><surname>Lewis</surname><given-names>D.A.</given-names></name>
<name><surname>Delany-Moretlwe</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from hiv-1-infected African women</article-title><source>J. Clin. Microbiol.</source><year>2013</year><volume>51</volume><fpage>4240</fpage><lpage>4242</lpage><pub-id pub-id-type="doi">10.1128/JCM.02144-13</pub-id><pub-id pub-id-type="pmid">24108613</pub-id>
</element-citation></ref><ref id="B88-viruses-16-01893"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Richter</surname><given-names>K.</given-names></name>
<name><surname>Becker</surname><given-names>P.</given-names></name>
<name><surname>Horton</surname><given-names>A.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
</person-group><article-title>Age-specific prevalence of cervical human papillomavirus infection and cytological abnormalities in women in Gauteng Province, South Africa</article-title><source>S. Afr. Med. J.</source><year>2013</year><volume>103</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.7196/SAMJ.6514</pub-id><pub-id pub-id-type="pmid">23971121</pub-id>
</element-citation></ref><ref id="B89-viruses-16-01893"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vogt</surname><given-names>S.L.</given-names></name>
<name><surname>Gravitt</surname><given-names>P.E.</given-names></name>
<name><surname>Martinson</surname><given-names>N.A.</given-names></name>
<name><surname>Hoffmann</surname><given-names>J.</given-names></name>
<name><surname>D&#x02019;Souza</surname><given-names>G.</given-names></name>
</person-group><article-title>Concordant oral-genital HPV infection in South Africa couples: Evidence for transmission</article-title><source>Front. Oncol.</source><year>2013</year><volume>3</volume><elocation-id>303</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2013.00303</pub-id><pub-id pub-id-type="pmid">24377087</pub-id>
</element-citation></ref><ref id="B90-viruses-16-01893"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adler</surname><given-names>D.H.</given-names></name>
<name><surname>Wallace</surname><given-names>M.</given-names></name>
<name><surname>Bennie</surname><given-names>T.</given-names></name>
<name><surname>Mrubata</surname><given-names>M.</given-names></name>
<name><surname>Abar</surname><given-names>B.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Bekker</surname><given-names>L.-G.</given-names></name>
</person-group><article-title>Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa</article-title><source>Infect. Dis. Obstet. Gynecol.</source><year>2014</year><volume>2014</volume><elocation-id>498048</elocation-id><pub-id pub-id-type="doi">10.1155/2014/498048</pub-id><pub-id pub-id-type="pmid">25389377</pub-id>
</element-citation></ref><ref id="B91-viruses-16-01893"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ameur</surname><given-names>A.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Bunikis</surname><given-names>I.</given-names></name>
<name><surname>H&#x000e4;ggqvist</surname><given-names>S.</given-names></name>
<name><surname>Lindau</surname><given-names>C.</given-names></name>
<name><surname>Lindberg</surname><given-names>J.H.</given-names></name>
<name><surname>Gustavsson</surname><given-names>I.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Gyllensten</surname><given-names>U.</given-names></name>
</person-group><article-title>Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><elocation-id>4398</elocation-id><pub-id pub-id-type="doi">10.1038/srep04398</pub-id><pub-id pub-id-type="pmid">24637939</pub-id>
</element-citation></ref><ref id="B92-viruses-16-01893"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Adewole</surname><given-names>I.</given-names></name>
<name><surname>Anorlu</surname><given-names>R.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Moodley</surname><given-names>M.</given-names></name>
<name><surname>Smith</surname><given-names>T.</given-names></name>
<name><surname>Snyman</surname><given-names>L.</given-names></name>
<name><surname>Wiredu</surname><given-names>E.</given-names></name>
<name><surname>Molijn</surname><given-names>A.</given-names></name>
<name><surname>Quint</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa</article-title><source>Int. J. Cancer</source><year>2013</year><volume>134</volume><fpage>1389</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1002/ijc.28425</pub-id><pub-id pub-id-type="pmid">23929250</pub-id>
</element-citation></ref><ref id="B93-viruses-16-01893"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDonald</surname><given-names>A.C.</given-names></name>
<name><surname>Tergas</surname><given-names>A.I.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa</article-title><source>Front. Oncol.</source><year>2014</year><volume>4</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2014.00048</pub-id><pub-id pub-id-type="pmid">24672770</pub-id>
</element-citation></ref><ref id="B94-viruses-16-01893"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adamson</surname><given-names>P.C.</given-names></name>
<name><surname>Huchko</surname><given-names>M.J.</given-names></name>
<name><surname>Moss</surname><given-names>A.M.</given-names></name>
<name><surname>Kinkel</surname><given-names>H.F.</given-names></name>
<name><surname>Medina-Marino</surname><given-names>A.</given-names></name>
</person-group><article-title>Acceptability and accuracy of cervical cancer screening using a self-collected tampon for HPV messenger-RNA testing among HIV infected women in South Africa</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0137299</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0137299</pub-id><pub-id pub-id-type="pmid">26332236</pub-id>
</element-citation></ref><ref id="B95-viruses-16-01893"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adler</surname><given-names>D.</given-names></name>
<name><surname>Wallace</surname><given-names>M.</given-names></name>
<name><surname>Bennie</surname><given-names>T.</given-names></name>
<name><surname>Abar</surname><given-names>B.</given-names></name>
<name><surname>Sadeghi</surname><given-names>R.</given-names></name>
<name><surname>Meiring</surname><given-names>T.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Bekker</surname><given-names>L.-G.</given-names></name>
</person-group><article-title>High Risk Human Papillomavirus Persistence Among HIV-infected Young Women in South Africa</article-title><source>Int. J. Infect. Dis.</source><year>2015</year><volume>33</volume><fpage>219</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2015.02.009</pub-id><pub-id pub-id-type="pmid">25697074</pub-id>
</element-citation></ref><ref id="B96-viruses-16-01893"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lebelo</surname><given-names>R.L.</given-names></name>
<name><surname>Bogers</surname><given-names>J.J.</given-names></name>
<name><surname>Thys</surname><given-names>S.</given-names></name>
<name><surname>Depuydt</surname><given-names>C.</given-names></name>
<name><surname>Benoy</surname><given-names>I.</given-names></name>
<name><surname>Selabe</surname><given-names>S.</given-names></name>
<name><surname>Bida</surname><given-names>M.N.</given-names></name>
<name><surname>Mphahlele</surname><given-names>M.</given-names></name>
</person-group><article-title>Detection, genotyping and quantitation of multiple hpv infections in south african women with cervical squamous cell carcinoma</article-title><source>J. Med. Virol.</source><year>2015</year><volume>87</volume><fpage>1594</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1002/jmv.24132</pub-id><pub-id pub-id-type="pmid">26037775</pub-id>
</element-citation></ref><ref id="B97-viruses-16-01893"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status</article-title><source>BMC Infect. Dis.</source><year>2015</year><volume>15</volume><elocation-id>459</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-015-1181-8</pub-id><pub-id pub-id-type="pmid">26502723</pub-id>
</element-citation></ref><ref id="B98-viruses-16-01893"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Goumbri-Lompo</surname><given-names>O.</given-names></name>
<name><surname>Doutre</surname><given-names>S.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Kelly</surname><given-names>H.</given-names></name>
<name><surname>Didelot</surname><given-names>M.-N.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women</article-title><source>Am. J. Ther.</source><year>2015</year><volume>68</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000428</pub-id><pub-id pub-id-type="pmid">25394189</pub-id>
</element-citation></ref><ref id="B99-viruses-16-01893"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tayib</surname><given-names>S.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
</person-group><article-title>Human papillomavirus genotypes and clinical management of genital warts in women attending a colposcopy clinic in Cape Town, South Africa</article-title><source>S. Afr. Med. J.</source><year>2015</year><volume>105</volume><elocation-id>679</elocation-id><pub-id pub-id-type="doi">10.7196/SAMJnew.7890</pub-id><pub-id pub-id-type="pmid">26449694</pub-id>
</element-citation></ref><ref id="B100-viruses-16-01893"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Aardt</surname><given-names>M.C.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Pienaar</surname><given-names>H.F.</given-names></name>
<name><surname>Karlsen</surname><given-names>F.</given-names></name>
<name><surname>Hovland</surname><given-names>S.</given-names></name>
<name><surname>Richter</surname><given-names>K.L.</given-names></name>
<name><surname>Becker</surname><given-names>P.</given-names></name>
</person-group><article-title>Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection</article-title><source>Int. J. Gynecol. Cancer</source><year>2015</year><volume>25</volume><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1097/IGC.0000000000000422</pub-id><pub-id pub-id-type="pmid">25950128</pub-id>
</element-citation></ref><ref id="B101-viruses-16-01893"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeier</surname><given-names>M.D.</given-names></name>
<name><surname>Botha</surname><given-names>M.H.</given-names></name>
<name><surname>Engelbrecht</surname><given-names>S.</given-names></name>
<name><surname>Machekano</surname><given-names>R.N.</given-names></name>
<name><surname>Jacobs</surname><given-names>G.B.</given-names></name>
<name><surname>Isaacs</surname><given-names>S.</given-names></name>
<name><surname>van Schalkwyk</surname><given-names>M.</given-names></name>
<name><surname>van der Merwe</surname><given-names>H.</given-names></name>
<name><surname>Mason</surname><given-names>D.</given-names></name>
<name><surname>Nachega</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV</article-title><source>AIDS</source><year>2015</year><volume>29</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000512</pub-id><pub-id pub-id-type="pmid">25387313</pub-id>
</element-citation></ref><ref id="B102-viruses-16-01893"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adler</surname><given-names>D.H.</given-names></name>
<name><surname>Wallace</surname><given-names>M.</given-names></name>
<name><surname>Bennie</surname><given-names>T.</given-names></name>
<name><surname>Abar</surname><given-names>B.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Bekker</surname><given-names>L.-G.</given-names></name>
</person-group><article-title>Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia</article-title><source>Adv. Virol.</source><year>2016</year><volume>2016</volume><elocation-id>7310894</elocation-id><pub-id pub-id-type="doi">10.1155/2016/7310894</pub-id><pub-id pub-id-type="pmid">26997954</pub-id>
</element-citation></ref><ref id="B103-viruses-16-01893"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ebrahim</surname><given-names>S.</given-names></name>
<name><surname>Mndende</surname><given-names>X.K.</given-names></name>
<name><surname>Kharsany</surname><given-names>A.B.M.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Naranbhai</surname><given-names>V.</given-names></name>
<name><surname>Frohlich</surname><given-names>J.</given-names></name>
<name><surname>Werner</surname><given-names>L.</given-names></name>
<name><surname>Samsunder</surname><given-names>N.</given-names></name>
<name><surname>Karim</surname><given-names>Q.A.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>High burden of human papillomavirus (HPV) infection among young women in KwaZulu-Natal, South Africa</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0146603</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0146603</pub-id><pub-id pub-id-type="pmid">26785408</pub-id>
</element-citation></ref><ref id="B104-viruses-16-01893"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Firnhaber</surname><given-names>C.</given-names></name>
<name><surname>Goeieman</surname><given-names>B.</given-names></name>
<name><surname>Faesen</surname><given-names>M.</given-names></name>
<name><surname>Levin</surname><given-names>S.</given-names></name>
<name><surname>Williams</surname><given-names>S.</given-names></name>
<name><surname>Rameotshela</surname><given-names>S.</given-names></name>
<name><surname>Swarts</surname><given-names>A.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<etal/>
</person-group><article-title>Prospective one year follow up of HIV infected women screened for cervical cancer using visual inspection with acetic acid, cytology and human papillomavirus testing in Johannesburg South Africa</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0144905</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0144905</pub-id><pub-id pub-id-type="pmid">26730710</pub-id>
</element-citation></ref><ref id="B105-viruses-16-01893"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kriek</surname><given-names>J.-M.</given-names></name>
<name><surname>Jaumdally</surname><given-names>S.Z.</given-names></name>
<name><surname>Masson</surname><given-names>L.</given-names></name>
<name><surname>Little</surname><given-names>F.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.</given-names></name>
<name><surname>Gumbi</surname><given-names>P.P.</given-names></name>
<name><surname>Barnabas</surname><given-names>S.L.</given-names></name>
<name><surname>Moodley</surname><given-names>J.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections</article-title><source>Virology</source><year>2016</year><volume>493</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2016.03.022</pub-id><pub-id pub-id-type="pmid">27065342</pub-id>
</element-citation></ref><ref id="B106-viruses-16-01893"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbatani</surname><given-names>N.</given-names></name>
<name><surname>Adams</surname><given-names>T.</given-names></name>
<name><surname>van Wijk</surname><given-names>L.</given-names></name>
<name><surname>Behrens</surname><given-names>C.</given-names></name>
<name><surname>Tam</surname><given-names>T.</given-names></name>
<name><surname>Wright</surname><given-names>T.</given-names></name>
<name><surname>Stoler</surname><given-names>M.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
</person-group><article-title>Performance of an human papillomavirus test in samples from women with histolopathologically confirmed invasive cervical cancer</article-title><source>J. Low. Genit. Tract Dis.</source><year>2016</year><volume>20</volume><fpage>151</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1097/LGT.0000000000000183</pub-id><pub-id pub-id-type="pmid">26855145</pub-id>
</element-citation></ref><ref id="B107-viruses-16-01893"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
<name><surname>Wilkin</surname><given-names>T.J.</given-names></name>
<name><surname>Goeieman</surname><given-names>B.</given-names></name>
<name><surname>Swarts</surname><given-names>A.</given-names></name>
<name><surname>Williams</surname><given-names>S.</given-names></name>
<name><surname>Levin</surname><given-names>S.</given-names></name>
<name><surname>Faesen</surname><given-names>M.</given-names></name>
<name><surname>Smith</surname><given-names>J.S.</given-names></name>
<name><surname>Chibwesha</surname><given-names>C.J.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<etal/>
</person-group><article-title>Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women</article-title><source>Papillomavirus Res.</source><year>2016</year><volume>2</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.pvr.2016.02.004</pub-id><pub-id pub-id-type="pmid">29074186</pub-id>
</element-citation></ref><ref id="B108-viruses-16-01893"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papasavvas</surname><given-names>E.</given-names></name>
<name><surname>Surrey</surname><given-names>L.F.</given-names></name>
<name><surname>Glencross</surname><given-names>D.K.</given-names></name>
<name><surname>Azzoni</surname><given-names>L.</given-names></name>
<name><surname>Joseph</surname><given-names>J.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Feldman</surname><given-names>M.D.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Siminya</surname><given-names>M.</given-names></name>
<name><surname>Swarts</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women</article-title><source>OncoImmunology</source><year>2016</year><volume>5</volume><elocation-id>e1128612</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2015.1128612</pub-id><pub-id pub-id-type="pmid">27467943</pub-id>
</element-citation></ref><ref id="B109-viruses-16-01893"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<name><surname>Kelly</surname><given-names>H.</given-names></name>
<name><surname>Magooa</surname><given-names>M.P.</given-names></name>
<name><surname>Djigma</surname><given-names>F.</given-names></name>
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Goumbri-Lompo</surname><given-names>O.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Doutre</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study</article-title><source>Br. J. Cancer</source><year>2016</year><volume>115</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/bjc.2016.207</pub-id><pub-id pub-id-type="pmid">27434037</pub-id>
</element-citation></ref><ref id="B110-viruses-16-01893"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Aardt</surname><given-names>M.C.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Snyman</surname><given-names>L.C.</given-names></name>
<name><surname>Richter</surname><given-names>K.L.</given-names></name>
<name><surname>Becker</surname><given-names>P.</given-names></name>
<name><surname>Mojaki</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Oncogenic and incidental HPV types associated with histologically confirmed cervical intraepithelial neoplasia in HIV-positive and HIV-negative South African women</article-title><source>S. Afr. Med. J.</source><year>2016</year><volume>106</volume><elocation-id>617</elocation-id><pub-id pub-id-type="doi">10.7196/SAMJ.2016.v106i6.10335</pub-id><pub-id pub-id-type="pmid">27245730</pub-id>
</element-citation></ref><ref id="B111-viruses-16-01893"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goeieman</surname><given-names>B.J.M.</given-names></name>
<name><surname>Firnhaber</surname><given-names>C.S.</given-names></name>
<name><surname>Jong</surname><given-names>E.</given-names></name>
<name><surname>Michelow</surname><given-names>P.M.</given-names></name>
<name><surname>Kegorilwe</surname><given-names>P.</given-names></name>
<name><surname>Swarts</surname><given-names>A.B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Allan</surname><given-names>B.M.</given-names></name>
<name><surname>Smith</surname><given-names>J.S.</given-names></name>
<name><surname>Wilkin</surname><given-names>T.J.</given-names></name>
</person-group><article-title>Prevalence of anal HPV and anal dysplasia in HIV-infected women from Johannesburg, South Africa</article-title><source>JAIDS J. Acquir. Immune Defic. Syndr.</source><year>2017</year><volume>75</volume><fpage>e59</fpage><lpage>e64</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000001300</pub-id><pub-id pub-id-type="pmid">28141783</pub-id>
</element-citation></ref><ref id="B112-viruses-16-01893"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>H.A.</given-names></name>
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Lompo</surname><given-names>O.</given-names></name>
<name><surname>Doutre</surname><given-names>S.</given-names></name>
<name><surname>Meda</surname><given-names>N.</given-names></name>
<name><surname>Weiss</surname><given-names>H.A.</given-names></name>
<etal/>
</person-group><article-title>Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0174117</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0174117</pub-id><pub-id pub-id-type="pmid">28333966</pub-id>
</element-citation></ref><ref id="B113-viruses-16-01893"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>H.A.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Lompo</surname><given-names>O.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Didelot</surname><given-names>M.-N.</given-names></name>
<name><surname>Nagot</surname><given-names>N.</given-names></name>
<name><surname>Meda</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: Effect of anti-retroviral therapy</article-title><source>AIDS</source><year>2017</year><volume>31</volume><fpage>273</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001301</pub-id><pub-id pub-id-type="pmid">27755107</pub-id>
</element-citation></ref><ref id="B114-viruses-16-01893"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbatha</surname><given-names>J.N.</given-names></name>
<name><surname>Taylor</surname><given-names>M.</given-names></name>
<name><surname>Kleppa</surname><given-names>E.</given-names></name>
<name><surname>Lillebo</surname><given-names>K.</given-names></name>
<name><surname>Galapaththi-Arachchige</surname><given-names>H.N.</given-names></name>
<name><surname>Singh</surname><given-names>D.</given-names></name>
<name><surname>Kjetland</surname><given-names>E.F.</given-names></name>
<name><surname>Baay</surname><given-names>M.F.D.</given-names></name>
<name><surname>Mkhize-Kwitshana</surname><given-names>Z.L.</given-names></name>
</person-group><article-title>High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: Implications for vaccination</article-title><source>Infect. Dis.</source><year>2017</year><volume>49</volume><fpage>601</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1080/23744235.2017.1312513</pub-id></element-citation></ref><ref id="B115-viruses-16-01893"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbatha</surname><given-names>J.N.</given-names></name>
<name><surname>Galappaththi-Arachchige</surname><given-names>H.N.</given-names></name>
<name><surname>Mtshali</surname><given-names>A.</given-names></name>
<name><surname>Taylor</surname><given-names>M.</given-names></name>
<name><surname>Ndhlovu</surname><given-names>P.D.</given-names></name>
<name><surname>Kjetland</surname><given-names>E.F.</given-names></name>
<name><surname>Baay</surname><given-names>M.F.D.</given-names></name>
<name><surname>Mkhize-Kwitshana</surname><given-names>Z.L.</given-names></name>
</person-group><article-title>Self-sampling for human papillomavirus testing among rural young women of KwaZulu-Natal, South Africa</article-title><source>BMC Res. Notes</source><year>2017</year><volume>10</volume><elocation-id>702</elocation-id><pub-id pub-id-type="doi">10.1186/s13104-017-3045-3</pub-id><pub-id pub-id-type="pmid">29208043</pub-id>
</element-citation></ref><ref id="B116-viruses-16-01893"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Wilkin</surname><given-names>T.</given-names></name>
<name><surname>Goeieman</surname><given-names>B.J.</given-names></name>
<name><surname>Jong</surname><given-names>E.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Swarts</surname><given-names>A.</given-names></name>
<name><surname>Smith</surname><given-names>J.S.</given-names></name>
<name><surname>Kegorilwe</surname><given-names>P.</given-names></name>
<name><surname>Firnhaber</surname><given-names>C.S.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women</article-title><source>Am. J. Clin. Pathol.</source><year>2017</year><volume>148</volume><fpage>148</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1093/ajcp/aqx050</pub-id><pub-id pub-id-type="pmid">28898982</pub-id>
</element-citation></ref><ref id="B117-viruses-16-01893"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rad</surname><given-names>A.M.</given-names></name>
<name><surname>S&#x000f8;rbye</surname><given-names>S.W.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Hovland</surname><given-names>S.M.</given-names></name>
<name><surname>Falang</surname><given-names>B.M.B.</given-names></name>
<name><surname>Louw</surname><given-names>M.</given-names></name>
<name><surname>Skjeldestad</surname><given-names>F.E.</given-names></name>
</person-group><article-title>HPV types in cervical cancer tissue in South Africa A head-to-head comparison by mRNA and DNA tests</article-title><source>Medicine</source><year>2017</year><volume>96</volume><elocation-id>e8752</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000008752</pub-id><pub-id pub-id-type="pmid">29381969</pub-id>
</element-citation></ref><ref id="B118-viruses-16-01893"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barnabas</surname><given-names>S.L.</given-names></name>
<name><surname>Dabee</surname><given-names>S.</given-names></name>
<name><surname>Passmore</surname><given-names>J.-A.S.</given-names></name>
<name><surname>Jaspan</surname><given-names>H.B.</given-names></name>
<name><surname>Lewis</surname><given-names>D.A.</given-names></name>
<name><surname>Jaumdally</surname><given-names>S.Z.</given-names></name>
<name><surname>Gamieldien</surname><given-names>H.</given-names></name>
<name><surname>Masson</surname><given-names>L.</given-names></name>
<name><surname>Muller</surname><given-names>E.</given-names></name>
<name><surname>Maseko</surname><given-names>V.D.</given-names></name>
<etal/>
</person-group><article-title>Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV</article-title><source>Int. J. STD AIDS</source><year>2017</year><volume>29</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1177/0956462417740487</pub-id><pub-id pub-id-type="pmid">29198180</pub-id>
</element-citation></ref><ref id="B119-viruses-16-01893"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Kelly</surname><given-names>H.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Pisa</surname><given-names>P.T.</given-names></name>
<name><surname>Gibson</surname><given-names>L.</given-names></name>
<name><surname>Didelot</surname><given-names>M.-N.</given-names></name>
<name><surname>Meda</surname><given-names>N.</given-names></name>
<name><surname>Weiss</surname><given-names>H.A.</given-names></name>
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0196018</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0196018</pub-id><pub-id pub-id-type="pmid">29715305</pub-id>
</element-citation></ref><ref id="B120-viruses-16-01893"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>H.</given-names></name>
<name><surname>Faust</surname><given-names>H.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Ngou</surname><given-names>J.</given-names></name>
<name><surname>Weiss</surname><given-names>H.A.</given-names></name>
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<name><surname>Dillner</surname><given-names>J.</given-names></name>
<name><surname>Delany-Moretlwe</surname><given-names>S.</given-names></name>
<name><surname>Mayaud</surname><given-names>P.</given-names></name>
</person-group><article-title>Human papillomavirus serology among women living with HIV: Type-Specific seroprevalence, seroconversion, and risk of cervical reinfection</article-title><source>J. Infect. Dis.</source><year>2018</year><volume>218</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy252</pub-id><pub-id pub-id-type="pmid">29850832</pub-id>
</element-citation></ref><ref id="B121-viruses-16-01893"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kremer</surname><given-names>W.W.</given-names></name>
<name><surname>Van Zummeren</surname><given-names>M.</given-names></name>
<name><surname>Heideman</surname><given-names>D.A.M.</given-names></name>
<name><surname>Lissenberg-Witte</surname><given-names>B.I.</given-names></name>
<name><surname>Snijders</surname><given-names>P.J.F.</given-names></name>
<name><surname>Steenbergen</surname><given-names>R.D.M.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Meijer</surname><given-names>C.J.L.M.</given-names></name>
</person-group><article-title>HPV16-related cervical cancers and precancers have increased levels of host cell DNA methylation in women living with HIV</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>3297</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19113297</pub-id><pub-id pub-id-type="pmid">30360578</pub-id>
</element-citation></ref><ref id="B122-viruses-16-01893"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>van Schalkwyk</surname><given-names>C.</given-names></name>
<name><surname>Hu</surname><given-names>N.-C.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Barnabas</surname><given-names>S.</given-names></name>
<name><surname>Dabee</surname><given-names>S.</given-names></name>
<name><surname>Jaspan</surname><given-names>H.</given-names></name>
<name><surname>Kriek</surname><given-names>J.-M.</given-names></name>
<name><surname>Jaumdally</surname><given-names>S.Z.</given-names></name>
<name><surname>Muller</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0190166</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0190166</pub-id><pub-id pub-id-type="pmid">29293566</pub-id>
</element-citation></ref><ref id="B123-viruses-16-01893"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liebenberg</surname><given-names>L.J.P.</given-names></name>
<name><surname>McKinnon</surname><given-names>L.R.</given-names></name>
<name><surname>Yende-Zuma</surname><given-names>N.</given-names></name>
<name><surname>Garrett</surname><given-names>N.</given-names></name>
<name><surname>Baxter</surname><given-names>C.</given-names></name>
<name><surname>Kharsany</surname><given-names>A.B.M.</given-names></name>
<name><surname>Archary</surname><given-names>D.</given-names></name>
<name><surname>Rositch</surname><given-names>A.</given-names></name>
<name><surname>Samsunder</surname><given-names>N.</given-names></name>
<name><surname>Mansoor</surname><given-names>L.E.</given-names></name>
<etal/>
</person-group><article-title>HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><elocation-id>5227</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13089-2</pub-id><pub-id pub-id-type="pmid">31745084</pub-id>
</element-citation></ref><ref id="B124-viruses-16-01893"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Onywera</surname><given-names>H.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
</person-group><article-title>The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection</article-title><source>Papillomavirus Res.</source><year>2019</year><volume>7</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.pvr.2019.04.006</pub-id><pub-id pub-id-type="pmid">30986570</pub-id>
</element-citation></ref><ref id="B125-viruses-16-01893"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papasavvas</surname><given-names>E.</given-names></name>
<name><surname>Kossenkov</surname><given-names>A.V.</given-names></name>
<name><surname>Azzoni</surname><given-names>L.</given-names></name>
<name><surname>Zetola</surname><given-names>N.M.</given-names></name>
<name><surname>Mackiewicz</surname><given-names>A.</given-names></name>
<name><surname>Ross</surname><given-names>B.N.</given-names></name>
<name><surname>Fair</surname><given-names>M.</given-names></name>
<name><surname>Vadrevu</surname><given-names>S.</given-names></name>
<name><surname>Ramogola-Masire</surname><given-names>D.</given-names></name>
<name><surname>Sanne</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+ HPV+ women</article-title><source>Carcinogenesis</source><year>2019</year><volume>40</volume><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgy149</pub-id><pub-id pub-id-type="pmid">30364933</pub-id>
</element-citation></ref><ref id="B126-viruses-16-01893"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chambuso</surname><given-names>R.</given-names></name>
<name><surname>Ramesar</surname><given-names>R.</given-names></name>
<name><surname>Kaambo</surname><given-names>E.</given-names></name>
<name><surname>Murahwa</surname><given-names>A.T.</given-names></name>
<name><surname>Abdallah</surname><given-names>M.O.</given-names></name>
<name><surname>De Sousa</surname><given-names>M.M.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Gray</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women. Medicine (United States)</article-title><source>Medicine</source><year>2020</year><volume>99</volume><elocation-id>e19273</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000019273</pub-id><pub-id pub-id-type="pmid">32118737</pub-id>
</element-citation></ref><ref id="B127-viruses-16-01893"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>L.G.</given-names></name>
<name><surname>Saidu</surname><given-names>R.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
<name><surname>Boa</surname><given-names>R.</given-names></name>
<name><surname>Tergas</surname><given-names>A.</given-names></name>
<name><surname>Moodley</surname><given-names>J.</given-names></name>
<name><surname>Persing</surname><given-names>D.</given-names></name>
<name><surname>Campbell</surname><given-names>S.</given-names></name>
<name><surname>Tsai</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women</article-title><source>Cancer Med.</source><year>2020</year><volume>9</volume><fpage>6813</fpage><lpage>6824</lpage><pub-id pub-id-type="doi">10.1002/cam4.3329</pub-id><pub-id pub-id-type="pmid">32706163</pub-id>
</element-citation></ref><ref id="B128-viruses-16-01893"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Saidu</surname><given-names>R.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
</person-group><article-title>Assessing the diagnostic value of Xpert HPV&#x02014;Authors&#x02019; reply</article-title><source>Lancet Glob. Health</source><year>2020</year><volume>8</volume><elocation-id>e998</elocation-id><pub-id pub-id-type="doi">10.1016/S2214-109X(20)30296-5</pub-id><pub-id pub-id-type="pmid">32710877</pub-id>
</element-citation></ref><ref id="B129-viruses-16-01893"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taku</surname><given-names>O.</given-names></name>
<name><surname>Businge</surname><given-names>C.B.</given-names></name>
<name><surname>Mdaka</surname><given-names>M.L.</given-names></name>
<name><surname>Phohlo</surname><given-names>K.</given-names></name>
<name><surname>Basera</surname><given-names>W.</given-names></name>
<name><surname>Garcia-Jardon</surname><given-names>M.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Gyllensten</surname><given-names>U.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
</person-group><article-title>Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa</article-title><source>Int. J. Infect. Dis.</source><year>2020</year><volume>95</volume><fpage>176</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.051</pub-id><pub-id pub-id-type="pmid">32114194</pub-id>
</element-citation></ref><ref id="B130-viruses-16-01893"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taku</surname><given-names>O.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Gustavsson</surname><given-names>I.</given-names></name>
<name><surname>Phohlo</surname><given-names>K.</given-names></name>
<name><surname>Garcia-Jardon</surname><given-names>M.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Businge</surname><given-names>C.B.</given-names></name>
<name><surname>Gyllensten</surname><given-names>U.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0241781</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0241781</pub-id><pub-id pub-id-type="pmid">33170891</pub-id>
</element-citation></ref><ref id="B131-viruses-16-01893"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van de Wijgert</surname><given-names>J.H.</given-names></name>
<name><surname>Gill</surname><given-names>A.C.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Verwijs</surname><given-names>M.C.</given-names></name>
<name><surname>Kelly</surname><given-names>H.A.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Delany-Moretlwe</surname><given-names>S.</given-names></name>
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<name><surname>Francis</surname><given-names>S.</given-names></name>
<name><surname>Darby</surname><given-names>A.C.</given-names></name>
<etal/>
</person-group><article-title>Human papillomavirus infection and cervical dysplasia in HIV-positive women: Potential role of the vaginal microbiota</article-title><source>AIDS</source><year>2020</year><volume>34</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000002381</pub-id><pub-id pub-id-type="pmid">31567164</pub-id>
</element-citation></ref><ref id="B132-viruses-16-01893"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wood</surname><given-names>N.H.</given-names></name>
<name><surname>Makua</surname><given-names>K.S.</given-names></name>
<name><surname>Lebelo</surname><given-names>R.L.</given-names></name>
<name><surname>Redzic</surname><given-names>N.</given-names></name>
<name><surname>Benoy</surname><given-names>I.</given-names></name>
<name><surname>Vanderveken</surname><given-names>O.M.</given-names></name>
<name><surname>Bogers</surname><given-names>J.</given-names></name>
</person-group><article-title>Human Papillomavirus Prevalence in Oral and Oropharyngeal Rinse and Gargle Specimens of Dental Patients and of an HIV-Positive Cohort from Pretoria, South Africa</article-title><source>Adv. Virol.</source><year>2020</year><volume>2020</volume><elocation-id>2395219</elocation-id><pub-id pub-id-type="doi">10.1155/2020/2395219</pub-id><pub-id pub-id-type="pmid">32908509</pub-id>
</element-citation></ref><ref id="B133-viruses-16-01893"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>H.A.</given-names></name>
<name><surname>Chikandiwa</surname><given-names>A.</given-names></name>
<name><surname>Sawadogo</surname><given-names>B.</given-names></name>
<name><surname>Gilham</surname><given-names>C.</given-names></name>
<name><surname>Michelow</surname><given-names>P.</given-names></name>
<name><surname>Lompo</surname><given-names>O.G.</given-names></name>
<name><surname>Omar</surname><given-names>T.</given-names></name>
<name><surname>Zan</surname><given-names>S.</given-names></name>
<name><surname>Magooa</surname><given-names>P.</given-names></name>
<name><surname>Segondy</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Diagnostic accuracy of cervical cancer screening and screening&#x02013;triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study</article-title><source>PLOS Med.</source><year>2021</year><volume>18</volume><elocation-id>e1003528</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1003528</pub-id><pub-id pub-id-type="pmid">33661957</pub-id>
</element-citation></ref><ref id="B134-viruses-16-01893"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Onywera</surname><given-names>H.</given-names></name>
<name><surname>Anejo-Okopi</surname><given-names>J.</given-names></name>
<name><surname>Mwapagha</surname><given-names>L.M.</given-names></name>
<name><surname>Okendo</surname><given-names>J.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0253218</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0253218</pub-id><pub-id pub-id-type="pmid">34143825</pub-id>
</element-citation></ref><ref id="B135-viruses-16-01893"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saidu</surname><given-names>R.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
<name><surname>Tergas</surname><given-names>A.</given-names></name>
<name><surname>Boa</surname><given-names>R.</given-names></name>
<name><surname>Moodley</surname><given-names>J.</given-names></name>
<name><surname>Svanholm-Barrie</surname><given-names>C.</given-names></name>
<name><surname>Persing</surname><given-names>D.</given-names></name>
<name><surname>Campbell</surname><given-names>S.</given-names></name>
<name><surname>Tsai</surname><given-names>W.-Y.</given-names></name>
<name><surname>Wright</surname><given-names>T.C.</given-names></name>
<etal/>
</person-group><article-title>Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening among Women in South Africa</article-title><source>J. Low. Genit. Tract Dis.</source><year>2020</year><volume>25</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1097/LGT.0000000000000575</pub-id></element-citation></ref><ref id="B136-viruses-16-01893"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taku</surname><given-names>O.</given-names></name>
<name><surname>Brink</surname><given-names>A.</given-names></name>
<name><surname>Meiring</surname><given-names>T.L.</given-names></name>
<name><surname>Phohlo</surname><given-names>K.</given-names></name>
<name><surname>Businge</surname><given-names>C.B.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa</article-title><source>PeerJ</source><year>2021</year><volume>9</volume><elocation-id>e10793</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.10793</pub-id><pub-id pub-id-type="pmid">33717675</pub-id>
</element-citation></ref><ref id="B137-viruses-16-01893"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taku</surname><given-names>O.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
<name><surname>Phohlo</surname><given-names>K.</given-names></name>
<name><surname>Garcia-Jardon</surname><given-names>M.</given-names></name>
<name><surname>Businge</surname><given-names>C.B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Distribution of human papillomavirus (Hpv) genotypes in hiv-negative and hiv-positive women with cervical intraepithelial lesions in the eastern cape province, south africa</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>280</elocation-id><pub-id pub-id-type="doi">10.3390/v13020280</pub-id><pub-id pub-id-type="pmid">33670231</pub-id>
</element-citation></ref><ref id="B138-viruses-16-01893"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiiti</surname><given-names>T.A.</given-names></name>
<name><surname>Mashishi</surname><given-names>T.L.</given-names></name>
<name><surname>Nkwinika</surname><given-names>V.V.</given-names></name>
<name><surname>Benoy</surname><given-names>I.</given-names></name>
<name><surname>Selabe</surname><given-names>S.G.</given-names></name>
<name><surname>Bogers</surname><given-names>J.</given-names></name>
<name><surname>Lebelo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa</article-title><source>Virol. J.</source><year>2021</year><volume>18</volume><elocation-id>192</elocation-id><pub-id pub-id-type="doi">10.1186/s12985-021-01662-5</pub-id><pub-id pub-id-type="pmid">34556128</pub-id>
</element-citation></ref><ref id="B139-viruses-16-01893"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiiti</surname><given-names>T.A.</given-names></name>
<name><surname>Mashishi</surname><given-names>T.L.</given-names></name>
<name><surname>Nkwinika</surname><given-names>V.V.</given-names></name>
<name><surname>Molefi</surname><given-names>K.A.</given-names></name>
<name><surname>Benoy</surname><given-names>I.</given-names></name>
<name><surname>Bogers</surname><given-names>J.</given-names></name>
<name><surname>Selabe</surname><given-names>S.G.</given-names></name>
<name><surname>Lebelo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa</article-title><source>J. Clin. Med.</source><year>2021</year><volume>10</volume><elocation-id>4817</elocation-id><pub-id pub-id-type="doi">10.3390/jcm10214817</pub-id><pub-id pub-id-type="pmid">34768334</pub-id>
</element-citation></ref><ref id="B140-viruses-16-01893"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naidoo</surname><given-names>K.</given-names></name>
<name><surname>Abbai</surname><given-names>N.</given-names></name>
<name><surname>Tinarwo</surname><given-names>P.</given-names></name>
<name><surname>Sebitloane</surname><given-names>M.</given-names></name>
</person-group><article-title>BV associated bacteria specifically BVAB 1 and BVAB 3 as biomarkers for HPV risk and progression of cervical neoplasia</article-title><source>Infect. Dis. Obstet. Gynecol.</source><year>2022</year><volume>2022</volume><elocation-id>9562937</elocation-id><pub-id pub-id-type="doi">10.1155/2022/9562937</pub-id><pub-id pub-id-type="pmid">35996693</pub-id>
</element-citation></ref><ref id="B141-viruses-16-01893"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Onywera</surname><given-names>H.</given-names></name>
<name><surname>Mabunda</surname><given-names>S.A.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Mbulawa</surname><given-names>Z.Z.A.</given-names></name>
</person-group><article-title>Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk</article-title><source>Front. Reprod. Health</source><year>2022</year><volume>4</volume><elocation-id>887736</elocation-id><pub-id pub-id-type="doi">10.3389/frph.2022.887736</pub-id><pub-id pub-id-type="pmid">36303664</pub-id>
</element-citation></ref><ref id="B142-viruses-16-01893"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiiti</surname><given-names>T.A.</given-names></name>
<name><surname>Selabe</surname><given-names>S.G.</given-names></name>
<name><surname>Bogers</surname><given-names>J.</given-names></name>
<name><surname>Lebelo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa</article-title><source>BMC Cancer</source><year>2022</year><volume>22</volume><elocation-id>854</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-022-09964-9</pub-id><pub-id pub-id-type="pmid">35931978</pub-id>
</element-citation></ref><ref id="B143-viruses-16-01893"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Botha</surname><given-names>M.H.</given-names></name>
<name><surname>Van der Merwe</surname><given-names>F.H.</given-names></name>
<name><surname>Snyman</surname><given-names>L.C.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.J.</given-names></name>
<name><surname>Visser</surname><given-names>C.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
</person-group><article-title>Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate</article-title><source>J. Low. Genit. Tract Dis.</source><year>2023</year><volume>27</volume><fpage>212</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">37097217</pub-id>
</element-citation></ref><ref id="B144-viruses-16-01893"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Saidu</surname><given-names>R.</given-names></name>
<name><surname>Boa</surname><given-names>R.</given-names></name>
<name><surname>Mbatani</surname><given-names>N.</given-names></name>
<name><surname>Castor</surname><given-names>D.</given-names></name>
<name><surname>Moodley</surname><given-names>J.</given-names></name>
<name><surname>Kuhn</surname><given-names>L.</given-names></name>
</person-group><article-title>Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: A demonstration study in South Africa</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>16182</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-43467-2</pub-id><pub-id pub-id-type="pmid">37758811</pub-id>
</element-citation></ref><ref id="B145-viruses-16-01893"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Happel</surname><given-names>A.-U.</given-names></name>
<name><surname>Balle</surname><given-names>C.</given-names></name>
<name><surname>Havyarimana</surname><given-names>E.</given-names></name>
<name><surname>Brown</surname><given-names>B.</given-names></name>
<name><surname>Maust</surname><given-names>B.S.</given-names></name>
<name><surname>Feng</surname><given-names>C.</given-names></name>
<name><surname>Yi</surname><given-names>B.H.</given-names></name>
<name><surname>Gill</surname><given-names>K.</given-names></name>
<name><surname>Bekker</surname><given-names>L.-G.</given-names></name>
<name><surname>Passmore</surname><given-names>J.-A.S.</given-names></name>
<etal/>
</person-group><article-title>Cervicovaginal Human Papillomavirus Genomes, Microbiota Composition and Cytokine Concentrations in South African Adolescents</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>758</elocation-id><pub-id pub-id-type="doi">10.3390/v15030758</pub-id><pub-id pub-id-type="pmid">36992467</pub-id>
</element-citation></ref><ref id="B146-viruses-16-01893"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maroga</surname><given-names>N.</given-names></name>
<name><surname>Mokoena</surname><given-names>T.</given-names></name>
<name><surname>Ledibane</surname><given-names>N.</given-names></name>
<name><surname>Musekiwa</surname><given-names>A.</given-names></name>
<name><surname>Bida</surname><given-names>M.</given-names></name>
<name><surname>Kgomo</surname><given-names>M.</given-names></name>
<name><surname>Lebelo</surname><given-names>R.</given-names></name>
</person-group><article-title>Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria, South Africa</article-title><source>S. Afr. Med. J.</source><year>2023</year><volume>113</volume><fpage>1283</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.7196/SAMJ.2023.v113i7.560</pub-id></element-citation></ref><ref id="B147-viruses-16-01893"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Snyman</surname><given-names>L.C.</given-names></name>
<name><surname>Richter</surname><given-names>K.L.</given-names></name>
<name><surname>Lukhwareni</surname><given-names>A.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
<name><surname>Botha</surname><given-names>M.H.</given-names></name>
<name><surname>Van Der Merwe</surname><given-names>F.H.</given-names></name>
<name><surname>Visser</surname><given-names>C.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
</person-group><article-title>Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women</article-title><source>Int. J. Gynecol. Cancer</source><year>2023</year><volume>33</volume><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1136/ijgc-2022-003897</pub-id><pub-id pub-id-type="pmid">36650011</pub-id>
</element-citation></ref><ref id="B148-viruses-16-01893"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000f8;rbye</surname><given-names>S.W.</given-names></name>
<name><surname>Falang</surname><given-names>B.M.</given-names></name>
<name><surname>Botha</surname><given-names>M.H.</given-names></name>
<name><surname>Snyman</surname><given-names>L.C.</given-names></name>
<name><surname>van der Merwe</surname><given-names>H.</given-names></name>
<name><surname>Visser</surname><given-names>C.</given-names></name>
<name><surname>Richter</surname><given-names>K.</given-names></name>
<name><surname>Dreyer</surname><given-names>G.</given-names></name>
</person-group><article-title>Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations</article-title><source>Cancers</source><year>2023</year><volume>15</volume><elocation-id>5453</elocation-id><pub-id pub-id-type="doi">10.3390/cancers15225453</pub-id><pub-id pub-id-type="pmid">38001713</pub-id>
</element-citation></ref><ref id="B149-viruses-16-01893"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vink</surname><given-names>F.J.</given-names></name>
<name><surname>Meijer</surname><given-names>C.J.L.M.</given-names></name>
<name><surname>Lissenberg-Witte</surname><given-names>B.I.</given-names></name>
<name><surname>Visser</surname><given-names>C.</given-names></name>
<name><surname>Duin</surname><given-names>S.</given-names></name>
<name><surname>Snyman</surname><given-names>L.C.</given-names></name>
<name><surname>Richter</surname><given-names>K.L.</given-names></name>
<name><surname>van der Merwe</surname><given-names>F.H.</given-names></name>
<name><surname>Botha</surname><given-names>M.H.</given-names></name>
<name><surname>Steenbergen</surname><given-names>R.D.M.</given-names></name>
<etal/>
</person-group><article-title>Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus</article-title><source>Clin. Infect. Dis.</source><year>2023</year><volume>76</volume><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1093/cid/ciac801</pub-id><pub-id pub-id-type="pmid">36366827</pub-id>
</element-citation></ref><ref id="B150-viruses-16-01893"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qulu</surname><given-names>W.</given-names></name>
<name><surname>Mtshali</surname><given-names>A.</given-names></name>
<name><surname>Osman</surname><given-names>F.</given-names></name>
<name><surname>Ndlela</surname><given-names>N.</given-names></name>
<name><surname>Ntuli</surname><given-names>L.</given-names></name>
<name><surname>Mzobe</surname><given-names>G.</given-names></name>
<name><surname>Naicker</surname><given-names>N.</given-names></name>
<name><surname>Garrett</surname><given-names>N.</given-names></name>
<name><surname>Rompalo</surname><given-names>A.</given-names></name>
<name><surname>Mindel</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0294698</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0294698</pub-id><pub-id pub-id-type="pmid">38032961</pub-id>
</element-citation></ref><ref id="B151-viruses-16-01893"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Downham</surname><given-names>L.</given-names></name>
<name><surname>Rol</surname><given-names>M.L.</given-names></name>
<name><surname>Forestier</surname><given-names>M.</given-names></name>
<name><surname>Romero</surname><given-names>P.</given-names></name>
<name><surname>Mendoza</surname><given-names>L.</given-names></name>
<name><surname>Mongelos</surname><given-names>P.</given-names></name>
<name><surname>Picconi</surname><given-names>M.A.</given-names></name>
<name><surname>Colucci</surname><given-names>M.C.</given-names></name>
<name><surname>Padin</surname><given-names>V.M.</given-names></name>
<name><surname>Flores</surname><given-names>A.P.</given-names></name>
<etal/>
</person-group><article-title>Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs</article-title><source>Int. J. Cancer</source><year>2024</year><volume>155</volume><fpage>816</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1002/ijc.34953</pub-id><pub-id pub-id-type="pmid">38602045</pub-id>
</element-citation></ref><ref id="B152-viruses-16-01893"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harbor</surname><given-names>S.N.</given-names></name>
<name><surname>Schneider</surname><given-names>J.W.</given-names></name>
<name><surname>Solomons</surname><given-names>N.</given-names></name>
<name><surname>Sanderson</surname><given-names>M.</given-names></name>
<name><surname>Afrogheh</surname><given-names>A.H.</given-names></name>
</person-group><article-title>An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort</article-title><source>Head Neck Pathol.</source><year>2024</year><volume>18</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.1007/s12105-024-01639-0</pub-id><pub-id pub-id-type="pmid">38709462</pub-id>
</element-citation></ref><ref id="B153-viruses-16-01893"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maueia</surname><given-names>C.</given-names></name>
<name><surname>Carulei</surname><given-names>O.</given-names></name>
<name><surname>Murahwa</surname><given-names>A.T.</given-names></name>
<name><surname>Taku</surname><given-names>O.</given-names></name>
<name><surname>Manjate</surname><given-names>A.</given-names></name>
<name><surname>Muss&#x000e1;</surname><given-names>T.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
</person-group><article-title>Identification of HPV16 Lineages in South African and Mozambican Women with Normal and Abnormal Cervical Cytology</article-title><source>Viruses</source><year>2024</year><volume>16</volume><elocation-id>1314</elocation-id><pub-id pub-id-type="doi">10.3390/v16081314</pub-id><pub-id pub-id-type="pmid">39205288</pub-id>
</element-citation></ref><ref id="B154-viruses-16-01893"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sebitloane</surname><given-names>H.M.</given-names></name>
<name><surname>Forestier</surname><given-names>M.</given-names></name>
<name><surname>Ginindza</surname><given-names>T.G.</given-names></name>
<name><surname>Dhlomo</surname><given-names>W.</given-names></name>
<name><surname>Moodley-Govender</surname><given-names>E.</given-names></name>
<name><surname>Darragh</surname><given-names>T.M.</given-names></name>
<name><surname>Baena</surname><given-names>A.</given-names></name>
<name><surname>Herrero</surname><given-names>R.</given-names></name>
<name><surname>Almonte</surname><given-names>M.</given-names></name>
<name><surname>Broutet</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Cervical cancer screening and treatment algorithms using human papillomavirus testing&#x02014;Lessons learnt from a South African pilot randomized controlled trial</article-title><source>Cancer Epidemiol. Biomark. Prev.</source><year>2024</year><volume>33</volume><fpage>779</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-23-0752</pub-id></element-citation></ref><ref id="B155-viruses-16-01893"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ogembo</surname><given-names>R.K.</given-names></name>
<name><surname>Gona</surname><given-names>P.N.</given-names></name>
<name><surname>Seymour</surname><given-names>A.J.</given-names></name>
<name><surname>Park</surname><given-names>H.S.-M.</given-names></name>
<name><surname>Bain</surname><given-names>P.A.</given-names></name>
<name><surname>Maranda</surname><given-names>L.</given-names></name>
<name><surname>Ogembo</surname><given-names>J.G.</given-names></name>
</person-group><article-title>Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0122488</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0122488</pub-id><pub-id pub-id-type="pmid">25875167</pub-id>
</element-citation></ref><ref id="B156-viruses-16-01893"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouassa</surname><given-names>R.-S.M.</given-names></name>
<name><surname>Nodjikouambaye</surname><given-names>Z.A.</given-names></name>
<name><surname>Sadjoli</surname><given-names>D.</given-names></name>
<name><surname>Adawaye</surname><given-names>C.</given-names></name>
<name><surname>P&#x000e9;r&#x000e9;</surname><given-names>H.</given-names></name>
<name><surname>Veyer</surname><given-names>D.</given-names></name>
<name><surname>Matta</surname><given-names>M.</given-names></name>
<name><surname>Robin</surname><given-names>L.</given-names></name>
<name><surname>Tonen-Wolyec</surname><given-names>S.</given-names></name>
<name><surname>Moussa</surname><given-names>A.M.</given-names></name>
<etal/>
</person-group><article-title>High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N&#x02019;Djamena, Chad</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0217486</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0217486</pub-id><pub-id pub-id-type="pmid">31158254</pub-id>
</element-citation></ref><ref id="B157-viruses-16-01893"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tchouaket</surname><given-names>M.C.T.</given-names></name>
<name><surname>Ka&#x02019;e</surname><given-names>A.C.</given-names></name>
<name><surname>Semengue</surname><given-names>E.N.J.</given-names></name>
<name><surname>Sosso</surname><given-names>S.M.</given-names></name>
<name><surname>Simo</surname><given-names>R.K.</given-names></name>
<name><surname>Yagai</surname><given-names>B.</given-names></name>
<name><surname>Nka</surname><given-names>A.D.</given-names></name>
<name><surname>Chenwi</surname><given-names>C.A.</given-names></name>
<name><surname>Abba</surname><given-names>A.</given-names></name>
<name><surname>Fainguem</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis</article-title><source>Pathogens</source><year>2023</year><volume>12</volume><elocation-id>1032</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens12081032</pub-id><pub-id pub-id-type="pmid">37623992</pub-id>
</element-citation></ref><ref id="B158-viruses-16-01893"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>T.-C.J.</given-names></name>
<name><surname>Hughes</surname><given-names>J.P.</given-names></name>
<name><surname>Feng</surname><given-names>Q.</given-names></name>
<name><surname>Hulbert</surname><given-names>A.B.</given-names></name>
<name><surname>Hawes</surname><given-names>S.E.</given-names></name>
<name><surname>Xi</surname><given-names>L.F.</given-names></name>
<name><surname>Schwartz</surname><given-names>S.M.</given-names></name>
<name><surname>Stern</surname><given-names>J.E.</given-names></name>
<name><surname>Koutsky</surname><given-names>L.A.</given-names></name>
<name><surname>Winer</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Epidemiology of human papillomavirus detected in the oral cavity and fingernails of mid-adult women</article-title><source>Sex. Transm. Dis.</source><year>2015</year><volume>42</volume><fpage>677</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1097/OLQ.0000000000000362</pub-id><pub-id pub-id-type="pmid">26562696</pub-id>
</element-citation></ref><ref id="B159-viruses-16-01893"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Sharma</surname><given-names>M.</given-names></name>
<name><surname>Tan</surname><given-names>N.</given-names></name>
<name><surname>Barnabas</surname><given-names>R.V.</given-names></name>
</person-group><article-title>HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer</article-title><source>AIDS</source><year>2018</year><volume>32</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001765</pub-id><pub-id pub-id-type="pmid">29369827</pub-id>
</element-citation></ref><ref id="B160-viruses-16-01893"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gumbi</surname><given-names>P.P.</given-names></name>
<name><surname>Nkwanyana</surname><given-names>N.N.</given-names></name>
<name><surname>Bere</surname><given-names>A.</given-names></name>
<name><surname>Burgers</surname><given-names>W.A.</given-names></name>
<name><surname>Gray</surname><given-names>C.M.</given-names></name>
<name><surname>Williamson</surname><given-names>A.-L.</given-names></name>
<name><surname>Hoffman</surname><given-names>M.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Passmore</surname><given-names>J.-A.S.</given-names></name>
</person-group><article-title>Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>8529</fpage><lpage>8536</lpage><pub-id pub-id-type="doi">10.1128/JVI.00183-08</pub-id><pub-id pub-id-type="pmid">18562528</pub-id>
</element-citation></ref><ref id="B161-viruses-16-01893"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nkwanyana</surname><given-names>N.N.</given-names></name>
<name><surname>Gumbi</surname><given-names>P.P.</given-names></name>
<name><surname>Roberts</surname><given-names>L.</given-names></name>
<name><surname>Denny</surname><given-names>L.</given-names></name>
<name><surname>Hanekom</surname><given-names>W.</given-names></name>
<name><surname>Soares</surname><given-names>A.</given-names></name>
<name><surname>Allan</surname><given-names>B.</given-names></name>
<name><surname>Williamson</surname><given-names>A.</given-names></name>
<name><surname>Coetzee</surname><given-names>D.</given-names></name>
<name><surname>Olivier</surname><given-names>A.J.</given-names></name>
<etal/>
</person-group><article-title>Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract</article-title><source>Immunology</source><year>2009</year><volume>128 (1pt2)</volume><fpage>e746</fpage><lpage>e757</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2009.03077.x</pub-id><pub-id pub-id-type="pmid">19740336</pub-id>
</element-citation></ref><ref id="B162-viruses-16-01893"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olukomogbon</surname><given-names>T.</given-names></name>
<name><surname>Akpobome</surname><given-names>B.</given-names></name>
<name><surname>Omole</surname><given-names>A.</given-names></name>
<collab>ACCME Research Group</collab>
<name><surname>Adebamowo</surname><given-names>C.A.</given-names></name>
<name><surname>Adebamowo</surname><given-names>S.N.</given-names></name>
</person-group><article-title>Association Between Cervical Inflammatory Mediators and Prevalent Cervical Human Papillomavirus Infection</article-title><source>JCO Glob. Oncol.</source><year>2024</year><volume>10</volume><elocation-id>e2300380</elocation-id><pub-id pub-id-type="doi">10.1200/GO.23.00380</pub-id><pub-id pub-id-type="pmid">38547441</pub-id>
</element-citation></ref><ref id="B163-viruses-16-01893"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Couper</surname><given-names>K.N.</given-names></name>
<name><surname>Blount</surname><given-names>D.G.</given-names></name>
<name><surname>Riley</surname><given-names>E.M.</given-names></name>
</person-group><article-title>IL-10: The master regulator of immunity to infection</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>5771</fpage><lpage>5777</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.9.5771</pub-id><pub-id pub-id-type="pmid">18424693</pub-id>
</element-citation></ref><ref id="B164-viruses-16-01893"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kemp</surname><given-names>T.J.</given-names></name>
<name><surname>Hildesheim</surname><given-names>A.</given-names></name>
<name><surname>Garc&#x000ed;a-Pi&#x000f1;eres</surname><given-names>A.</given-names></name>
<name><surname>Williams</surname><given-names>M.C.</given-names></name>
<name><surname>Shearer</surname><given-names>G.M.</given-names></name>
<name><surname>Rodriguez</surname><given-names>A.C.</given-names></name>
<name><surname>Schiffman</surname><given-names>M.</given-names></name>
<name><surname>Burk</surname><given-names>R.</given-names></name>
<name><surname>Freer</surname><given-names>E.</given-names></name>
<name><surname>Bonilla</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection</article-title><source>Cancer Epidemiol. Biomark. Prev.</source><year>2010</year><volume>19</volume><fpage>1954</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-10-0184</pub-id><pub-id pub-id-type="pmid">20647411</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01893-f001"><label>Figure 1</label><caption><p>PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for studies on the prevalence and distribution of HPV types and their interaction with cervicovaginal microbiota and cytokine profile among women living in South Africa.</p></caption><graphic xlink:href="viruses-16-01893-g001" position="float"/></fig><fig position="float" id="viruses-16-01893-f002"><label>Figure 2</label><caption><p>Forest plot showing the overall prevalence of HPV in South African women based on various studies. The random effects model estimated a pooled prevalence of 58% (95% CI: 52&#x02013;64%). Significant heterogeneity was observed among the included studies (I<sup>2</sup> = 99.1%, &#x003c4;<sup>2</sup> = 0.9489, <italic toggle="yes">p</italic> &#x0003c; 0.001).</p></caption><graphic xlink:href="viruses-16-01893-g002" position="float"/></fig><fig position="float" id="viruses-16-01893-f003"><label>Figure 3</label><caption><p>Geographic distribution of sample types used in HPV studies across South African provinces. The map illustrates the geographic distribution of various sample types used in HPV studies across South Africa. Each dot represents an individual study, and the colour of the dots indicates the sample type: pink for cervical, green for vaginal, yellow for oral, red for anal, blue for breast tissue, brown for cervical and oral, black for laryngeal, turquoise for cervical and blood, and purple for biopsy. The position of each dot within a province does not necessarily reflect the exact location of the study within that province. The map highlights key regions, such as Gauteng and the Western Cape, where HPV research has been most prominent. The Gauteng province, located in the top-right corner, is zoomed out to ensure all sample dots are visible.</p></caption><graphic xlink:href="viruses-16-01893-g003" position="float"/></fig><fig position="float" id="viruses-16-01893-f004"><label>Figure 4</label><caption><p>Overall prevalence (%) of HR-HPV genotypes detected in studies conducted from 1989 to 2024.</p></caption><graphic xlink:href="viruses-16-01893-g004" position="float"/></fig><fig position="float" id="viruses-16-01893-f005"><label>Figure 5</label><caption><p>Detection trends of HPV types 16, 18, 35, and 52 from 2005 to 2024. The graphs show the percentage detection of each type over time from all the studies included. Peaks in detection for HPV-16 and HPV-18 are observed from 2005 to 2024, while HPV-35 and 52 show variable detection trends across the years.</p></caption><graphic xlink:href="viruses-16-01893-g005" position="float"/></fig><fig position="float" id="viruses-16-01893-f006"><label>Figure 6</label><caption><p>Overall prevalence (%) of LR-HPV genotypes detected in studies conducted from 1996 to 2023.</p></caption><graphic xlink:href="viruses-16-01893-g006" position="float"/></fig><fig position="float" id="viruses-16-01893-f007"><label>Figure 7</label><caption><p>Distribution and prevalence of HR-HPV genotypes among HIV-negative (<bold>A</bold>) and HIV-positive (<bold>B</bold>) women. The pie charts represent the percentage prevalence of each HR-HPV genotype within each group.</p></caption><graphic xlink:href="viruses-16-01893-g007" position="float"/></fig><fig position="float" id="viruses-16-01893-f008"><label>Figure 8</label><caption><p>Distribution of LR-HPV genotypes among HIV-negative (<bold>A</bold>) and HIV-positive (<bold>B</bold>) women. The pie charts represent the percentage prevalence of each LR-HPV genotype within each group.</p></caption><graphic xlink:href="viruses-16-01893-g008" position="float"/></fig><fig position="float" id="viruses-16-01893-f009"><label>Figure 9</label><caption><p>Network analysis of cervicovaginal microbiota composition correlated with HPV infection status. Negative correlations are displayed in blue, while positive correlations are in red. Bacterial species associated with bacterial vaginosis (BV) are shown in purple, <italic toggle="yes">Lactobacillus</italic>-dominated species are in green, and those bacterial species with association not clearly indicated are shown in black. Taxonomic clusters indicate groups of taxa sharing the same hierarchical classification levels, denoting biological relatedness. Bacterial taxa significantly associated with each HPV category are marked with an asterisk above the species name.</p></caption><graphic xlink:href="viruses-16-01893-g009" position="float"/></fig><fig position="float" id="viruses-16-01893-f010"><label>Figure 10</label><caption><p>Venn diagrams illustrating elevated cytokine concentrations in women with HPV infection, HIV infection, and bacterial vaginosis (BV) and lowered cytokines in HPV-negative women. The cytokines significantly associated with each category are indicated by the asterisk.</p></caption><graphic xlink:href="viruses-16-01893-g010" position="float"/></fig><table-wrap position="float" id="viruses-16-01893-t001"><object-id pub-id-type="pii">viruses-16-01893-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of the 120 included studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Province</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Period</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Type</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HPV Detection Method</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Setting</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Williamson et al. [<xref rid="B38-viruses-16-01893" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1989</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>#</sup> N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">^ SBH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper et al. [<xref rid="B39-viruses-16-01893" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 1990</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x000f0;</sup> NISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper et al. [<xref rid="B40-viruses-16-01893" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Johnson et al. [<xref rid="B41-viruses-16-01893" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SBH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Padayachee et al. [<xref rid="B42-viruses-16-01893" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>$</sup> ISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper et al. [<xref rid="B43-viruses-16-01893" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1992</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1988</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Padayachee et al. [<xref rid="B44-viruses-16-01893" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1993</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1982 to 1988</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laryngeal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Williamson et al. [<xref rid="B45-viruses-16-01893" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1994</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SBH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wright et al. [<xref rid="B46-viruses-16-01893" ref-type="bibr">46</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1995</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991 to 1993 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Grayson et al. [<xref rid="B47-viruses-16-01893" ref-type="bibr">47</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1996</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1974 to 1995</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NISH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ramesar et al. [<xref rid="B48-viruses-16-01893" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1996</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SBH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic and private practices</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chetty et al. [<xref rid="B49-viruses-16-01893" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1997</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">* PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denny et al. [<xref rid="B50-viruses-16-01893" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1996</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x003b1;</sup> HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kuhn et al. [<xref rid="B51-viruses-16-01893" ref-type="bibr">51</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wright et al. [<xref rid="B52-viruses-16-01893" ref-type="bibr">52</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 1999</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kay et al. [<xref rid="B53-viruses-16-01893" ref-type="bibr">53</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1997</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nested PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Passmore et al. [<xref rid="B54-viruses-16-01893" ref-type="bibr">54</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kay et al. [<xref rid="B55-viruses-16-01893" ref-type="bibr">55</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2003</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1993 to 1997</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x00026;</sup> RFLP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kay et al. [<xref rid="B56-viruses-16-01893" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2005</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 2001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and blood</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nested PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urban and peri-urban areas</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allan et al. [<xref rid="B57-viruses-16-01893" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 2001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospitals and community health services</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Boy et al. [<xref rid="B58-viruses-16-01893" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 2003 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x020ac;</sup> RT-PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Departments of Anatomical and Oral Pathology</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Passmore et al. [<xref rid="B59-viruses-16-01893" ref-type="bibr">59</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x0221e;</sup> RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jones et al. [<xref rid="B60-viruses-16-01893" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community Health centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Passmore et al. [<xref rid="B61-viruses-16-01893" ref-type="bibr">61</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allan et al. [<xref rid="B62-viruses-16-01893" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1999 to 2001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospitals and community health services</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denny et al. [<xref rid="B63-viruses-16-01893" ref-type="bibr">63</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002 to 2003</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marais et al. [<xref rid="B64-viruses-16-01893" ref-type="bibr">64</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marais et al. [<xref rid="B65-viruses-16-01893" ref-type="bibr">65</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x000b0;</sup> RLB</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Richter et al. [<xref rid="B66-viruses-16-01893" ref-type="bibr">66</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospitals and clinics </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firnhaber et al. [<xref rid="B67-viruses-16-01893" ref-type="bibr">67</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B68-viruses-16-01893" ref-type="bibr">68</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigations of genital HPV transmission</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moodley et al. [<xref rid="B69-viruses-16-01893" ref-type="bibr">69</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Said et al. [<xref rid="B70-viruses-16-01893" ref-type="bibr">70</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Participating in a phase III microbicide study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denny et al. [<xref rid="B71-viruses-16-01893" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">community outreach </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firnhaber et al. [<xref rid="B72-viruses-16-01893" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kuhn et al. [<xref rid="B73-viruses-16-01893" ref-type="bibr">73</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B74-viruses-16-01893" ref-type="bibr">74</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 and 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigations of genital HPV transmission</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moodley et al. [<xref rid="B75-viruses-16-01893" ref-type="bibr">75</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taylor et al. [<xref rid="B76-viruses-16-01893" ref-type="bibr">76</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community education and outreach activities</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Auvert et al. [<xref rid="B77-viruses-16-01893" ref-type="bibr">77</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1996 to 2000</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multicentre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firnhaber et al. [<xref rid="B78-viruses-16-01893" ref-type="bibr">78</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x000a5;</sup> HPV-4cLIA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taylor et al. [<xref rid="B79-viruses-16-01893" ref-type="bibr">79</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical trial</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang et al. [<xref rid="B80-viruses-16-01893" ref-type="bibr">80</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA and HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical cancer prevention trial</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Vuyst et al. [<xref rid="B81-viruses-16-01893" ref-type="bibr">81</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007 to 2009 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x00394;</sup> EIA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dols et al. [<xref rid="B82-viruses-16-01893" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limpopo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x00293;</sup> SPF10 PCR-DEIA-LiPA25</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B83-viruses-16-01893" ref-type="bibr">83</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">McDonald et al. [<xref rid="B84-viruses-16-01893" ref-type="bibr">84</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998 to 1999</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meiring et al. [<xref rid="B85-viruses-16-01893" ref-type="bibr">85</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Illumina sequencing </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bere et al. [<xref rid="B86-viruses-16-01893" ref-type="bibr">86</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genital wart</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV genotyping</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ngou et al. [<xref rid="B87-viruses-16-01893" ref-type="bibr">87</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> 2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Richter et al. [<xref rid="B88-viruses-16-01893" ref-type="bibr">88</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009 to 2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RealTime</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vogt et al. [<xref rid="B89-viruses-16-01893" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x000a9;</sup> IBH </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adler et al. [<xref rid="B90-viruses-16-01893" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012 to 2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ameur et al. [<xref rid="B91-viruses-16-01893" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denny et al. [<xref rid="B92-viruses-16-01893" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007 to 2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SPF10 PCR-DEIA-LiPA25</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B12-viruses-16-01893" ref-type="bibr">12</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical and oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">McDonald et al. [<xref rid="B93-viruses-16-01893" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2000 to 2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hybrid Capture II test</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Three clinical sites</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adamson et al. [<xref rid="B94-viruses-16-01893" ref-type="bibr">94</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aptima HPV assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adler et al. [<xref rid="B95-viruses-16-01893" ref-type="bibr">95</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012 to 2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lebelo et al. [<xref rid="B96-viruses-16-01893" ref-type="bibr">96</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TaqMan-based quantitative qPCR </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B97-viruses-16-01893" ref-type="bibr">97</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006 to 2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ngou et al. [<xref rid="B98-viruses-16-01893" ref-type="bibr">98</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>A</sup> INNO-LiPA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tayib et al. [<xref rid="B99-viruses-16-01893" ref-type="bibr">99</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van Aardt et al. [<xref rid="B100-viruses-16-01893" ref-type="bibr">100</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2003 to 2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Referred for staging and treatment of histologically confirmed invasive cervical cancer</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zeier et al. [<xref rid="B101-viruses-16-01893" ref-type="bibr">101</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009 to2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x02260;</sup> cART na&#x000ef;ve HIV infected women </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adler et al. [<xref rid="B102-viruses-16-01893" ref-type="bibr">102</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">October 2013 &#x00026; March 2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Youth community centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ebrahim et al. [<xref rid="B103-viruses-16-01893" ref-type="bibr">103</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004 to 2007</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary health care Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Firnhaber et al. [<xref rid="B104-viruses-16-01893" ref-type="bibr">104</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">March 2010 to August 2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV treatment clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kriek et al. [<xref rid="B105-viruses-16-01893" ref-type="bibr">105</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbatani et al. [<xref rid="B106-viruses-16-01893" ref-type="bibr">106</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Women diagnosed with invasive cervical cancer </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B107-viruses-16-01893" ref-type="bibr">107</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009 to 2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Papasavvas et al. [<xref rid="B108-viruses-16-01893" ref-type="bibr">108</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Segondy et al. [<xref rid="B109-viruses-16-01893" ref-type="bibr">109</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 and 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centres and clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van Aardt et al. [<xref rid="B110-viruses-16-01893" ref-type="bibr">110</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010 to 2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Public healthcare facilities</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goeieman et al. [<xref rid="B111-viruses-16-01893" ref-type="bibr">111</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kelly et al. [<xref rid="B112-viruses-16-01893" ref-type="bibr">112</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV treatment centres </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kelly et al. [<xref rid="B113-viruses-16-01893" ref-type="bibr">113</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV treatment centres </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbatha et al. [<xref rid="B114-viruses-16-01893" ref-type="bibr">114</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010 and 2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EIA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Schools in two rural areas </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbatha et al. [<xref rid="B115-viruses-16-01893" ref-type="bibr">115</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010 and 2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EIA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B116-viruses-16-01893" ref-type="bibr">116</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012 to 2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rad et al. [<xref rid="B117-viruses-16-01893" ref-type="bibr">117</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008 to 2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLB</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Institute of Community Medicine (ISM) and Department of Clinical Pathology</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Barnabas et al. [<xref rid="B118-viruses-16-01893" ref-type="bibr">118</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng and Western Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chikandiwa et al. [<xref rid="B119-viruses-16-01893" ref-type="bibr">119</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 and October 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centres and communities </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kelly et al. [<xref rid="B120-viruses-16-01893" ref-type="bibr">120</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centres and communities</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kremer et al. [<xref rid="B121-viruses-16-01893" ref-type="bibr">121</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013 and 2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x02228;</sup> GP5+/6+ PCR enzyme immunoassay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Women with istologically confirmed stages of cervical<break/>disease</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B122-viruses-16-01893" ref-type="bibr">122</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013 and 2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Communities and community outreach programs </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liebenberg et al. [<xref rid="B123-viruses-16-01893" ref-type="bibr">123</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rural and urban areas</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onywera et al. [<xref rid="B124-viruses-16-01893" ref-type="bibr">124</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gugulethu</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Papasavvas et al. [<xref rid="B125-viruses-16-01893" ref-type="bibr">125</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>&#x02122;</sup> ART-treated HIV + HPV + coinfected women</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chambuso et al. [<xref rid="B126-viruses-16-01893" ref-type="bibr">126</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 and 2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic and Hospitals</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Johnson et al. [<xref rid="B127-viruses-16-01893" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kuhn et al. [<xref rid="B128-viruses-16-01893" ref-type="bibr">128</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 and 2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community outreach and clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taku et al. [<xref rid="B129-viruses-16-01893" ref-type="bibr">129</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017 to 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taku et al. [<xref rid="B130-viruses-16-01893" ref-type="bibr">130</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017 to 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community health clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van de Wijgert et al. [<xref rid="B131-viruses-16-01893" ref-type="bibr">131</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 and 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centres and communities </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wood et al. [<xref rid="B132-viruses-16-01893" ref-type="bibr">132</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbott RealTime</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre and clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kelly et al. [<xref rid="B133-viruses-16-01893" ref-type="bibr">133</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011 to 2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INNO-LiPA </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ART initiation site</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B22-viruses-16-01893" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV education intervention </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onywera et al. [<xref rid="B134-viruses-16-01893" ref-type="bibr">134</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV Couples Cohort</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saidu et al. [<xref rid="B135-viruses-16-01893" ref-type="bibr">135</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening population and screening population</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taku et al. [<xref rid="B136-viruses-16-01893" ref-type="bibr">136</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017 to 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community health clinic and the referral clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taku et al. [<xref rid="B137-viruses-16-01893" ref-type="bibr">137</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017 to 2019 </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV direct-flow chip</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tiiti et al. [<xref rid="B138-viruses-16-01893" ref-type="bibr">138</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 to 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbott RealTime</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tiiti et al. [<xref rid="B139-viruses-16-01893" ref-type="bibr">139</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 and 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbott Realtime</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mbulawa et al. [<xref rid="B19-viruses-16-01893" ref-type="bibr">19</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018 to 2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naidoo et al. [<xref rid="B140-viruses-16-01893" ref-type="bibr">140</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019 to 2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onywera et al. [<xref rid="B141-viruses-16-01893" ref-type="bibr">141</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eastern Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Schools </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tiiti et al. [<xref rid="B142-viruses-16-01893" ref-type="bibr">142</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 to 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbott Realtime</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Botha et al. [<xref rid="B143-viruses-16-01893" ref-type="bibr">143</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Onclarity assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metropolitan areas</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denny et al. [<xref rid="B144-viruses-16-01893" ref-type="bibr">144</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017 to 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Happel et al. [<xref rid="B145-viruses-16-01893" ref-type="bibr">145</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015 to 2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shotgun DNA sequencing of purified virions</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Youth centre</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maroga et al. [<xref rid="B146-viruses-16-01893" ref-type="bibr">146</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015 to 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast tissue </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Snyman et al. [<xref rid="B147-viruses-16-01893" ref-type="bibr">147</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCII</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics and Hospital</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S&#x000f8;rbye et al. [<xref rid="B148-viruses-16-01893" ref-type="bibr">148</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng and Western Cape</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 to 2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre-Tect HPV-Proofer&#x02019;7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vink et al. [<xref rid="B149-viruses-16-01893" ref-type="bibr">149</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 to 2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cobas 4800 HPV test</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinics</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Qulu et al. [<xref rid="B150-viruses-16-01893" ref-type="bibr">150</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016 to 2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RLA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downham et al. [<xref rid="B151-viruses-16-01893" ref-type="bibr">151</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019 to 2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV DNA Test</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Centre </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Habour et al. [<xref rid="B152-viruses-16-01893" ref-type="bibr">152</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western Cape </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009 to 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HybriSpot HPV Direct Flow Chip</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hospital </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maueia et al. [<xref rid="B153-viruses-16-01893" ref-type="bibr">153</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gauteng</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018 to 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cervical</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HybriSpot HPV Direct Flow Chip</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sebitloane et al. [<xref rid="B154-viruses-16-01893" ref-type="bibr">154</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KwaZulu-Natal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneXpert HPV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinic</td></tr></tbody></table><table-wrap-foot><fn><p><sup>#</sup> N/A: Not indicated, ^ SBH: Southern Blot Hybridization, <sup>$</sup> ISH: In situ hybridization, <sup>&#x000f0;</sup> NISH: Non-Isotopic in Situ Hybridization, * PCR: Polymerase Chain Reaction, <sup>&#x003b1;</sup> HCII: Hybrid Capture II test, <sup>&#x00026;</sup> RFLP: Restriction fragment length polymorphism, <sup>&#x020ac;</sup> RT-PCR: Realtime-PCR, <sup>&#x0221e;</sup> RLA: Roche Linear Array, <sup>&#x000b0;</sup> RLB: Roche Line Blot, <sup>&#x000a5;</sup> HPV-4cLIA: HPV-4competitive Luminex Immuno Assay, <sup>&#x00394;</sup> EIA: Enzyme immunoassay, <sup>&#x000a9;</sup> IBH: Line blot hybridization, <sup>&#x00293;</sup> SPF10 PCR-DEIA-LiPA25: Specific Primer F10 Polymerase Chain Reaction-DNA Enzyme Immuno Assay-Line Probe Assay25, <sup>A</sup> INNO-LiPA: Innovative Line Probe Assay, <sup>&#x02260;</sup> cART: combination Antiretroviral Therapy, <sup>&#x02228;</sup> GP5+/6+ PCR EIA: General Primer 5+/6+ Polymerase Chain Reaction Enzyme Immuno Assay, <sup>&#x02122;</sup> ART: Antiretroviral Therapy.</p></fn></table-wrap-foot></table-wrap></floats-group></article>